Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Martine J. Piccart
Based on 125 articles published since 2007
||||
Expertise Level
The expertise of Martine J. Piccart ranks in the
  • Top 0.014%
  • ... of 254,621 published authors worldwide on Breast Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 125 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Piccart, Martine   ·   Piccart, M J   ·   Piccart, Martine J   ·   Piccart, M
Work Locations
Details
Most likely:    Miscellaneous cities in Belgium      
2018
  • Academic Promoting Team, Institut Jules Bordet, Blvd de Waterloo 121, 7th Floor., 1000 Brussels, Belgium. Electronic address: · Academic Promoting Team, Institut Jules Bordet, Belgium. · Medical Department, Institut Jules Bordet, Belgium. · Medical Oncology Department, University Hospital Leuven, Belgium. · Research Department, Institut Jules Bordet, Belgium. · Pubmed 29751334
Probable:    Jules Bordet Institute      
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA. · Indiana University Medical CTR, Indianapolis, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Pubmed 27927580
  • Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. Electronic address: · Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, 4000 Liège, Belgium. · Centre Hospitalier de Luxembourg, 1210 Luxembour, GD Luxembourg, Belgium. · Department of Radiotherapy, CHU Liège, 4000 Liège, Belgium. · Department of Internal Medicine and Oncology, Clinique St-Joseph Espérance, 4000 Liège, Belgium. · Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, 59100 Prato, Italy. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 29096156
  • Hematology/Oncology Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Frontier Science (Scotland) Ltd., Kincraig, UK. · Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Radiation Oncology Department, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, MD, USA. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Department of Oncology, Division of Cancer, Oslo University Hospital, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Medical Oncology Unit, Azienda Istituti Ospitalieri, Cremona, Italy. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Case Western Reserve University, Cleveland, OH, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 28376188
  • WELBIO and Institute of Interdisciplinary Research (IRIBHM), Campus Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium · ULB-Cancer Research Center (U-CRC) Université Libre de Bruxelles, Brussels, Belgium. · WELBIO and Institute of Interdisciplinary Research (IRIBHM), Campus Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Laboratoire de Biologie Moléculaire du Gène, Faculté des Sciences, Université libre de Bruxelles (ULB), Brussels, Belgium. · Center for Microscopy and Molecular Imaging, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Tumor Bank of the Jules Bordet Institute, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Biobank of the Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · ULB-Cancer Research Center (U-CRC) Université Libre de Bruxelles, Brussels, Belgium · Pubmed 28566333
  • Medical Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. · Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands; Department of Radiology, University Medical Centre Utrecht, Utrecht, The Netherlands. · Department of Surgery, Haaglanden Medical Centre, The Hague, The Netherlands. · Department of Statistics, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Department of Product Development and Support, Agendia, Amsterdam, The Netherlands. · Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland; Ludwig Center for Cancer Research, University of Lausanne, Epalinges, Switzerland; Department of Oncology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland. · Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Surgery, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Amsterdam, The Netherlands. Electronic address: · Pubmed 28477490
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Prometheus Laboratories, San Diego, California. · Foundation Medicine, Cambridge, Massachusetts. · Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, North Carolina. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Department of Gynecology, University of Ulm, Ulm, Germany. · Novartis Pharmaceuticals, Basel, Switzerland. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Pubmed 28381415
  • Breast Data Centre, Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Institute for Oncology and Radiology of Serbia, National Cancer Research Centre, Belgrade, Republic of Serbia. · Breast International Group, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Hospital Albert Einstein, São Paulo, Brazil. · Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Pubmed 28151718
2016
  • a Breast International Group (BIG) , Brussels , Belgium. · b European Organization for Research and Treatment of Cancer (EORTC) , Brussels , Belgium. · c Institut Jules Bordet, Université Libre de Bruxelles , Brussels , Belgium. · Pubmed 27741402
  • European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium. · Breast International Group (BIG), Brussels, Belgium. · University of Illinois and College of Medicine, Department of Molecular and Integrative Physiology, IL, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 27643748
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium. Electronic address: · Pubmed 27430154
  • European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium. Electronic address: · European Centre for Disease Prevention and Control, Stockholm, Sweden. · European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium. · Breast Reconstruction Quality of Life Group, University of Bristol, Bristol, UK. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group, Brussels, Belgium. · Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Academic Medical Center, Amsterdam, Netherlands. · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Pubmed 27396647
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Department of Gynecology and Obstetrics, Ludwig-Maximilians-Universität, Munich, Germany. · Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Center of Experimental Medicine, Hamburg, Germany. · Circulating Biomarker Lab, SIRIC, Institut Curie, Paris, France. · Department of Medical Oncology, Institut Bergonié, Bordeaux, France. · Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna) and ACR-ITR VIEnna, Kaiser Franz Josef-Spital, Kundratstrasse 3, 1100 Vienna, Austria. · Medical and Scientific Affairs, F. Hoffmann-La Roche AG, Diagnostics Division, Basel, Switzerland. · European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium. · Breast International Group Headquarters, Brussels, Belgium. · Janssen Diagnostics LLC, NJ, USA. · Department of Gynecology and Obstetrics, Universitätsklinikum Ulm, Ulm, Germany. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Circulating Biomarker Lab, SIRIC, Institut Curie, Paris, France; Medical Oncology Department, Institut Curie, Université Paris Descartes, France. · Pubmed 27289552
  • Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group (BIG, aisbl), Brussels, Belgium. · Department of Medical Oncology, Hassan II University Hospital, Fez, Morocco. · Pubmed 26119941
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group (BIG aisbl), Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Medigene AG, Planegg, Germany. · Department of Biostatistics, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 27454930
  • Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Peninsula Oncology Centre, Melbourne, VIC, Australia. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · The Royal Marsden Hospital, London, UK. · Hospital Arnau de Vilanova, Lleida, Spain. · Sarah Cannon Research Institute, and Tennessee Oncology, Nashville, TN, USA. · Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic. · University of Alabama, Birmingham, AL, USA. · National University Hospital, Singapore. · Royal Melbourne Hospital, Parkville, VIC, Australia. · Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Herlev University Hospital, Copenhagen, Denmark. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Washington University School of Medicine, St Louis, MO, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Genentech, South San Francisco, CA, USA. · Barts Cancer Institute, Queen Mary University of London, London, UK. · Pubmed 27155741
  • EORTC-Headquarters, Medical Department, Brussels, Belgium. Electronic address: · Acıbadem Üniversitesi İç Hastalıkları/Tıbbi Onkoloji, Turkey. Electronic address: · EORTC-Headquarters, Statistical Department, Belgium. Electronic address: · Institute Bergonie, Bordeaux, France. Electronic address: · GZA Sint Augustinus, Antwerp, Belgium. Electronic address: · Ctr Becquerel-Rouen, France. Electronic address: · Radboudumc Nijmegen/Maastricht UMC+, Netherlands. Electronic address: · ZNA Middelheim, Belgium. Electronic address: · University Clinic Golnik, Slovenia. Electronic address: · Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. Electronic address: · NHS-Lothian, University of Edinburgh, Edinburgh, United Kingdom. Electronic address: · Pubmed 26724641
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast and Gynecological Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Avera Cancer Institute, Sioux Falls, South Dakota. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark11Department of Oncology, Odense University Hospital, Odense, Denmark12AgeCare, Odense University Hospital, Odense. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France14INSERM U1018, CESP, Université Paris-Sud, Villejuif France. · Pubmed 26633571
  • German Breast Group, Neu-Isenburg, Germany · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Surgery, Oncology and Gastroenterology, University of Padua, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · German Breast Group, Neu-Isenburg, Germany. · Frontier Science Scotland, Kincraig, UK. · Department of Medical Oncology, University of Verona, Verona, Italy. · Institute of Pathology, Charité Universitätsmedizin Berlin, and German Cancer Consortium (DKTK), Berlin. · Department of Obstetrics and Gynecology, University Hospital Kiel, Kiel, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussel, Belgium. · Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Obstetrics and Gynecology, Helios-Klinikum, Berlin-Buch, Germany. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 27177864
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
  • Unit of Biostatistics and Epidemiology, Gustave Roussy, Villejuif University Paris-Sud, University Paris-Saclay, UVSQ, CESP, INSERM, Villejuif Plateform Ligue nationale contre le cancer for meta-analyses in oncology, Gustave Roussy, Villejuif, France Institut Jules Bordet, Université Libre de Bruxelles, Brussels · Institut Jules Bordet, Université Libre de Bruxelles, Brussels Breast International Group (BIG), Brussels, Belgium. · Unit of Biostatistics and Epidemiology, Gustave Roussy, Villejuif. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany. · Department of Oncology, University of Edinburgh, Edinburgh, UK. · Rush University Medical Center, Chicago, USA. · Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Breast Unit, Royal Marsden Hospital, London, UK. · Scientific Direction, IRCCS National Cancer Research Centre "Giovanni Paolo II," Bari, Italy. · The Institute of Breast Oncology, Sheba Medical Center, Tel Hashomer, Israel. · Breast Cancer Diseases Unit and Department of Medical Oncology, Saint Louis Hospital, APHP, Paris, France. · German Breast Group, GBG ForschungsGmbH, Neu-Isenburg, Germany. · Department of Pathology, Centre Jean Perrin, EA 4233, University of Auvergne, Clermont-Ferrand, France. · Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles. · University of Miami School of Medicine, Comprehensive Cancer Research Group Inc, Columbia Cancer Research Network of Florida, Miami, USA. · IDDI, Louvain-la-Neuve, Hasselt University, Hasselt, Belgium. · Pubmed 26961151
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J. C. Heuson, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France. · Pubmed 26931736
  • Department of Medical Oncology, Institut Jules Bordet/Université libre de Bruxelles, 1 Rue Héger-Bordet, 1000 Bruxelles, Brussels, Belgium. · Department of Hematology and Oncology, Hôpital du Sacré-Cœur de Montréal/Université de Montréal, 5400 Boulevard Gouin, Montreal, Quebec H4J 1C5, Canada. · Pubmed 26787281
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue Yawkey, Boston, 1238, USA. · Department of Medical Oncology and Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK. · Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Royal Marsden Hospital, and Institute of Cancer Research, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Edinburgh Cancer Research Centre, Western general Hospital, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Department of Gynecology and Obstetrics and Multidisciplinary Breast Cancer Center, Helios Klinikum, Berlin-Buch, Germany. · Department of Gynecology and Obstetrics, Klinikum Off enbach, Off Enbach, Germany. · Department of Medical Oncology, The Andrew Love Cancer Centre, Deakin University, Geelong, Australia. · Department of Medical Oncology, San Raffaele Institute, Milan, Italy. · European Institute of Oncology, Milan, Italy. · Swiss Center for Breast Health, Sant'Anna Clinic, Lugano-Sorengo, Switzerland. · Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School, Boston, USA. · Pubmed 26708471
  • Laboratory of Molecular and Medical Oncology, Vrije Universiteit Brussel, Brussels, Belgium. · Department of Medical Oncology, Oncologisch Centrum, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Jules Bordet Institute, Brussels, Belgium. · Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium. · Pubmed 26010302
  • University of California, San Francisco, San Francisco, CA · Netherlands Cancer Institute, Amsterdam, the Netherlands · Institut Jules Bordet, Brussels, Belgium · Pubmed 27959762
2015
  • Breast International Group (BIG, aisbl), Brussels, Belgium. · Breast European Adjuvant Studies Team (BrEAST), Brussels, Belgium. · Institut Jules Bordet, Université Libre des Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 26255196
  • Breast International Group (BIG)-aisbl c/o Jules Bordet Institute, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · University College London Cancer Institute, Cancer Research UK Lung Cancer Centre of Excellence, Paul O'Gorman Building, Huntley Street, London WC1E 6DD, UK. · Jules Bordet Institute, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Pubmed 25895611
  • Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Electronic address: · European Institute of Oncology, Division of Medical Oncology, Milan, Italy. · Department of Clinical Research, Institut Curie, Paris, France. · Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK, London Research Institute, London, UK. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breakthrough Breast Cancer Research Centre, Institute of Cancer Research and Kings College London School of Medicine, London, UK. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25840656
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 25712461
  • Department of Oncology, University Hospital Zurich, Zurich, Switzerland. Electronic address: · EORTC Headquarters, Brussels, Belgium. Electronic address: · Division of Medical Oncology, Second University of Naples, Naples, Italy. Electronic address: · KU Leuven - University of Leuven, Department of Oncology, Experimental Radiation Oncology, B-3000 Leuven, Belgium; University Hospitals Leuven, Department of Radiation Oncology, B-3000 Leuven, Belgium. Electronic address: · Medical University of Vienna, Vienna, Austria. Electronic address: · Institut de Cancérologie Gustave-Roussy, Villejuif, France; University Paris-Sud, Le Kremlin Bicêtre, Paris, France. Electronic address: · University of Dublin, Trinity College, Dublin, Ireland. Electronic address: · Université Paris Descartes, Paris, France. Electronic address: · Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. Electronic address: · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · VU Medical Center, Amsterdam, The Netherlands. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · University Hospitals Leuven and KU Leuven, Leuven, Belgium. Electronic address: · University Hospitals Leuven and KU Leuven, Leuven, Belgium. Electronic address: · Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: · Pubmed 25533737
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000 Brussels, Belgium. · Pubmed 25286972
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pathology Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital, Campus Mitte, German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland. · Pubmed 26358523
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · IRIBHM, Université Libre de Bruxelles (ULB), Route de Lennik, 808-1070 Brussels, Belgium. · Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK. · Department of Pathology, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Molecular Immunology Unit, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · Department of Medicine, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · Department of Genetics, Hôpital Erasme, Route de Lennik, 808-1070 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium; Department of Medicine, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. Electronic address: · IRIBHM, Université Libre de Bruxelles (ULB), Route de Lennik, 808-1070 Brussels, Belgium; WELBIO, Route de Lennik, 808-1070 Brussels, Belgium. Electronic address: · Pubmed 26440892
  • Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital Campus Mitte, and German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University, Hospital and Helsinki University, Helsinki, Finland. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Pathology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, University of Tampere and Tampere University Hospital, PO Box 607, FIN 33101, Tampere, Finland. · Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Pubmed 26234940
  • Department of Medical Oncology, National Institute of Oncology, Université Mohammed V de Rabat, Avenue Allal El Fassi, 10100, Rabat, Morocco. · Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000, Brussels, Belgium. · Department of Medical Oncology, National Institute of Oncology, Université Mohammed V de Rabat, Avenue Allal El Fassi, 10100, Rabat, Morocco. · Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000, Brussels, Belgium. · Pubmed 25971303
  • Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumouri (IRST) - IRCCS, Meldola, Italy. · Department of Internal Medicine, University of Genoa and IRCCS Azienda Ospedaliera Universitaria San Martino - IST, Genoa, Italy. · Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, UK. · Translational Breast Cancer Genomics Lab, Division of Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · VIB Vesalius Research Center, KU Leuven, Campus Gasthuisberg, Herestraat 49, Bus 912, Leuven, Belgium. · Pathology Unit, 'G.B. Morgagni-L. Pierantoni' Hospital, Forlì, Italy. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Pathology Department, Jules Bordet Institute, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Medical Oncology, Jules Bordet Institute, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Haematology, University of Cambridge, Cambridge, UK. · Department of Haematology, Addenbrooke's Hospital, Cambridge, UK. · Pubmed 25850943
  • Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science (Scotland) Ltd., Inverness-shire, Scotland. · Clinical Research, Monogram Biosciences, Inc., South San Francisco, California. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Center, Department of Obstetrics and Gynecology, and CCC LMU, University of Munich, Munich, Germany. · Genetics and Genomics Program, Yale School of Medicine, New Haven, Connecticut. · Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania. · Department of Gynecology and Midwifery, University Hospital Kiel, Kiel, Germany. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Jules Bordet Institute, Brussels, Belgium. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 25467182
2014
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, Arome, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, DE, USA. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · Advanced BC.org, New York, USA. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25244983
  • BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25336696
  • 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Breast Cancer Translational Research Laboratory - J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory - J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. · Medical Oncology, Nepean Hospital, Penrith, NSW, Australia. · Breast International Group Executive Board. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium [3] Breast International Group Executive Board. · Pubmed 25225904
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. Electronic address: · Pubmed 25151406
  • US Food and Drug Administration, Silver Spring, MD, USA. Electronic address: · US Food and Drug Administration, Silver Spring, MD, USA. · HELIOS Klinikum, Berlin, Germany. · German Breast Group, Neu-Isenburg, Germany. · National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA. · Institut Bergonié INSERM U916 and Université Bordeaux Segalen, Bordeaux, France. · Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian, UK. · San Raffaele Scientific Institute, Milan, Italy. · Fondazione Michelangelo, Milan, Italy. · Medstar Washington Hospital Center, Washington, DC, USA. · EORTC Headquarters, Brussels, Belgium. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · St Gertrauden Hospital, Berlin, Germany. · MD Anderson Cancer Center Orlando, Orlando, FL, USA. · KarolinskaInstitutet and University Hospital, Stockholm, Sweden. · NN Petrov Research Institute of Oncology, St Petersburg, Russia. · University Women's Hospital, Kiel, Germany. · Jules Bordet Institute, Brussels, Belgium. · Frauenklinik des Universitätsklinikums, Erlangen, Germany. · Universitäts Frauenklinik, Rostock, Germany. · Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · Hospital of the Ludwig Maximilian University of Munich, Munich, Germany. · Pubmed 24529560
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Department of Breast Medical Oncology, Multidisciplinary Breast Cancer Research Program, University of Texas MD Anderson Cancer Center, Houston, USA. · Institut de Cancérologie de l'Ouest, René Gauducheau, Centre de Recherche en Cancérologie, Nantes Saint Herblain, France. · Department of Medicine, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo. · Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. · Breast Cancer Centers, Memorial Cancer Institute, Hollywood. · Breast Oncology and Clinical Trials Education, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Oncologic Centre, AZ Nikolaas, Sint-Niklaas, Belgium. · Sarah Cannon Research Institute, Nashville, USA. · Centre des Maladies du Sein Deschênes-Fabia, CHU-Hôpital du Saint Sacrement, Québec, Canada. · Multidisciplinary Breast Centre and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Ironwood Cancer & Research Centers, Chandler. · Novartis Pharmaceuticals Corporation, East Hanover. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 25231953
  • Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France · European Organisation for Research and Treatment of Cancer (EORTC), Brussels. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France. · Centre George-François Leclerc, Dijon. · Ensemble Hospitalier de L'Institut Curie, Hopital René Huguenin, St-Cloud. · Centre Paul Strauss, Strasbourg. · Centre Val D'Aurelle-Paul Lamarque, Montpellier, France. · Medical University, Gdansk, Poland. · Centre Henri Becquerel, Rouen, France. · Geneva University Hospital, Geneva Swiss Group for Clinical Cancer Research (SAKK), Bern. · Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Institute of Oncology, Ljubljana University Clinic Golnik, Golnik, Slovenia. · Institut de Cancérologie de L'Ouest (ICO), Centre René Gauducheau, Nantes Centre Paul Papin, Angers. · Centre Alexis Vautrin, Nancy, France. · Department of Clinical Sciences, Lund University, Lund Skåne Department of Oncology, Skåne University Hospital, Lund. · Swedish Breast Cancer Group (SweBCG), Stockholm Department of Oncology, Karolinska Institutet, Radiumhemmet and Karolinska University Hospital, Stockholm, Sweden. · Cancer Services, Edinburgh University Anglo-Celtic Cooperative Oncology Group (ACCOG), Edinburgh, UK. · Pubmed 24618153
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. · Research Center of Epidemiology, Biostatistics and Clinical Research, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP598, Route de Lennik 808, 1070 Brussels, Belgium. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Department of Medical Oncology, Hirslanden Clinic Aarau, Schänisweg, 5001 Aarau, Switzerland. · Research Center of Social Approaches of Health, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP 596, Route de Lennik, 808, 1070 Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. Electronic address: · Pubmed 25446375
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal · European School of Oncology, Milan, Italy European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, Denmark. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · AdvancedBC.org, New York. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25234545
  • Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · OncoDNA, Gosselies, KU Leuven, Leuven. · Laboratory of Translational Genetics, KU Leuven, Leuven Vesalius Research Center, VIB, Leuven, Belgium. · Department of Biostatistic and Epidemiology, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Radiology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · Department of Pathology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels · Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels · Pubmed 25185240
  • Breast Data Center, Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium; Medical Oncology Department, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, Serbia. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Pathological Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Department of Medical Oncology, "Sandro Pitigliani" Hospital of Prato, Prato, Italy. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, Boulevard de Waterloo 125, Brussels, Belgium; Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. Electronic address: · Pubmed 24768477
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne,Australia · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Service de Biostatistique et D'Epidemiology, Gustave Roussy, Universite Paris-Sud, Villejuif, France. · Department of Anatomical Pathology, Institut Jules Bordet, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, Tampere University Hospital, Tampere. · Department of Oncology, Helsinki University Central Hospital, Helsinki. · Cancer Center, Kuopio University Hospital, Kuopio, Finland. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · German Breast Group, Neu-Isenburg. · Charité University Hospital, Institute of Pathology, Berlin, Germany. · Immunology in Cancer and Infection Laboratory, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute; School of Medicine, University of Queensland, Herston, Australia. · Pubmed 24608200
  • Department of Medical Oncology, Institut Jules Bordet, Brussels. · Data Centre, Institut Jules Bordet, Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Brussels · Pubmed 24562450
2013
  • Author's Affiliation: Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24062313
2017
  • From the German Breast Group, Neu-Isenburg, Germany (G.M.); Frontier Science (Scotland), Kincraig, United Kingdom (M. Procter); the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), and Institut Jules Bordet, Université Libre de Bruxelles (M. Piccart) - all in Brussels; Roche Pharma (M.B., E.C., A.K.) and the Department of Cardiology, Cardio-Oncology, Bern University Hospital (T.S.) - both in Bern, Switzerland; the Department of Pathology, European Institute of Oncology, University of Milan, Milan (G.V.); the National Institute of Oncology, Budapest, Hungary (I.L.); Centre François Baclesse, Caen, France (C.L.); the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.A.Y.); Instituto Nacional de Câncer, Rio de Janeiro (J. Bines); Dana-Farber Cancer Institute, Harvard Medical School, Harvard T. H. Chan School of Public Health, and Frontier Science and Technology Research Foundation - all in Boston (R.D.G.); and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (J. Baselga). · Pubmed 28581356
2016
  • From Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal (F.C.); Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (L.J.V.); European Organization for Research and Treatment of Cancer Headquarters (J.B., L. Slaets, V.G., B.M., K.T.), Breast International Group Headquarters (T.G., C. Straehle), and Institut Jules Bordet, Université Libre de Bruxelles (C. Sotiriou, M.P.), Brussels, and Centre Hospitalier Universitaire Université Catholique de Louvain, Namur (P.V.) - both in Belgium; University of Milan and Istituto Europeo di Oncologia (G.V.) and Europa Donna-European Breast Cancer Coalition (S.K.), Milan, and Azienda Istituti Ospitalieri di Cremona, Cremona (R.P.) - both in Italy; Gustave Roussy, Villejuif (S.D., M.S.), Institut Curie Paris Sciences et Lettres, Université Paris Descartes, Sorbonne Paris Cité, Paris (J.-Y.P.). Institut Curie-Hôpital Rene Huguenin, Saint-Cloud (E.B.), and Centre Georges-Francois-Leclerc, Dijon (S.C.) - all in France; Swiss Institute of Bioinformatics and University of Lausanne, Lausanne, Switzerland (M.D.); Agendia (A.M.G., L. Stork) and the Netherlands Cancer Institute (R.B., E.R.), Amsterdam, Alrijne Ziekenhuis, Rijnland Leiderdorp (P.A.N.), Jeroen Bosch Hospital, 's-Hertogenbosch (T.J.S.), and Medisch Centrum Alkmaar, Alkmaar (J.M.H.) - all in the Netherlands; Institute of Oncology, Ljubljana, Slovenia (E.M.); Evangelisches Krankenhaus Bethesda, Duisburg, Germany (U.N.); University of Texas Health Sciences Center, San Antonio (P.R.); Hospital Universitario Vall d'Hebron, Barcelona (I.T.R.); Imperial College London, London (G.T.); and University of Texas M.D. Anderson Cancer Center, Houston (A.M.T.). · Pubmed 27557300
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
2015
  • Breast International Group Headquarters (BIG-aisbl), Brussels 1000, Belgium; email: , · Pubmed 25386936
2014
  • Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 25049332
  • Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium. · Pubmed 24667715
  • Breast Cancer Translational Research Laboratory (BCTL), Institut Jules Bordet, Brussels, Belgium. · Pubmed 25412710
  • Department of Surgery and GROW School for Oncology and Developmental Biology (MM, MLS), Department of Surgery and Radiology (LMvR), Department of Medical Oncology, GROW School for Oncology and Developmental Biology (VCGTH), and Department of Epidemiology and GROW School for Oncology and Developmental Biology (ACV), Maastricht University Medical Center, Maastricht, the Netherlands; Department of Surgery, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands (LJAS); Division of Medical Oncology, Luzerner Kantonsspital, Lucerne, Switzerland (SA); Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian (DAC), Edinburgh Breast Unit (JMD), Western General Hospital, Edinburgh, UK; Cedars-Sinai Medical Center, Los Angeles, CA (AEG); Rutgers Cancer Institute of New Jersey, New Brunswick, NJ (BGH); Mater Centre Radiation Oncology Service, Princess Alexandra Hospital, Brisbane, Australia (BEH); Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center and Professor of Medicine, Weill Cornell Medical College, New York, NY (CAH); University of Arkansas for Medical Sciences, Winthrop P. Rockefeller Cancer Institute, Little Rock, AR (VSK); Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, Australia (BK); Interdisciplinary Breast Centre, Department of Gynaecology and Obstetrics, Klinikum Esslingen, Germany (TK); University of Miami Miller School of Medicine, Miami, FL (MEL); Radiation Oncology (BDS) and Department of Surgical Oncology, Division of Surgery (AL), University of Texas/MD Anderson Cancer Center, Houston, TX; Institut Jules Bordet, Université Libre de Bruxelles, Head of Medicine Department, Brussels, Belgium (MP); Surgery, University Medical Center, Leiden, the Netherlands (CJHvdV); Breast Service, Memorial Sloan-Kettering Cancer Center, Evelyn Lauder Breast Center, New York, NY(KJVZ); Antwerp University Hospital, Department of Medical Oncology, Edegem, Belgium (JBV); Department of Pathology, European Institute of · Pubmed 25381395
  • Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumDepartment of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxel · Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 24825746
2013
  • From the Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Edinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, United Kingdom; and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Pubmed 23714441
  • Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Pubmed 23459626
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23990869
  • Breast Cancer Translational Research Laboratory (BCTL) J.C. Heuson, Institut Jules Bordet, Blvd de Waterloo, 125, 1000 Brussels, Belgium. · Pubmed 23341518
  • Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY; James G. Greger Jr, GlaxoSmithKline, Collegeville, PA; Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles; Phuong Dinh, Breast International Group, Brussels; Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium; Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland; Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research, London, United Kingdom; Serena Di Cosimo, IRCCS Fondazione Instituto Nazionale dei Tumori, Milan, Italy; Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain; Christian Jackisch, Kilinikum Offenbach, Offenbach; Bahriye Aktas, Kliniken Essen-Mitte, Evang, Essen; Holger Eidtmann, University Hospital Kiel, Kiel, Germany; Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; Chiun-Sheng Huang, National Taiwan University Hospital; Ruey Kuen Hsieh, Mackey Memorial Hospital, Taipei, Taiwan; and Lydia Dreosti, University of Pretoria, Pretoria, South Africa. · Pubmed 24248687
  • Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24092940
  • Institut Jules Bordet, Boulevard de Waterloo, 125, 1000 Brussels, Belgium. · Pubmed 23902243
  • Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23778140
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23739063
  • Breast Cancer Translational Research Laboratory, JC Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23638089
  • Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Brussels, Belgium. · Pubmed 23301057
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23169515
  • Breast Cancer Translation Research Laboratory J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23028037
2012
  • Breast Cancer Translational Research Laboratory, Faculty of Medicine, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Pubmed 22652232
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22508827
  • Breast Cancer Translational Research Laboratory (BCTL) J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22261811
  • Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, 125 Bld de Waterloo, Brussels 1000, Belgium. · Pubmed 22235100
2011
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, L'Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 21918439
  • Department of Medical Oncology, Jules Bordet Institute, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Pubmed 21342046
  • Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium. · Pubmed 21289366
  • Breast Cancer Translational Research Laboratory, Faculty of Medicine, Université Libre de Bruxelles, Institut Jules Bordet, Bruxelles 1000, Belgium. · Pubmed 22043058
  • Translational Research Unit, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 21738599
  • Department of Medical Oncology, Institut Jules Bordet, Universite Libre de Bruxelles, 1000 Brussels, Belgium. · Pubmed 21354372
  • Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. · Pubmed 21264346
2010
  • Jules Bordet Institute, Department of Medical Oncology, Boulevard Waterloo, 121,1000 Brussels, Belgium. · Pubmed 20735311
  • Breast Cancer Translational Research Laboratory JC Heuson, Jules Bordet Institute, Brussels, Belgium. · Pubmed 20856894
  • Department of Research, Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, East Melbourne 3002, Australia. · Pubmed 20479250
  • Functional Genomics and Translational Research Unit, Medical Oncology Department, Jules Bordet Institute, Boulevard de Waterloo, Brussels, 1000, Belgium. · Pubmed 20156340
2009
  • Translational Research Unit, Jules Bordet Institute, Brussels, Belgium. · Pubmed 19744330
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 19289395
Probable:    Universite Libre de Bruxelles      
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA. · Indiana University Medical CTR, Indianapolis, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Pubmed 27927580
  • Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. Electronic address: · Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, 4000 Liège, Belgium. · Centre Hospitalier de Luxembourg, 1210 Luxembour, GD Luxembourg, Belgium. · Department of Radiotherapy, CHU Liège, 4000 Liège, Belgium. · Department of Internal Medicine and Oncology, Clinique St-Joseph Espérance, 4000 Liège, Belgium. · Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, 59100 Prato, Italy. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 29096156
  • German Breast Group, Neu-Isenburg, Germany; Sana-Klinikum Offenbach, Germany. Electronic address: · SOLTI Breast Cancer Research Group, Barcelona, Spain. · German Breast Group, Neu-Isenburg, Germany. · Breast International Group, Brussels, Belgium. · Gustave Roussy, Service de Biostatistique et d'Epidémiologie, Villejuif, France; CESP, Inserm U1018, Univ. Paris Sud, Univ. Paris-Saclay, Villejuif, France. · Institute of Pathology, Charité University Hospital, Berlin, Germany. · Luisenkrankenhaus Düsseldorf, Germany. · Hospital Clinico Universitario de Valencia, Spain. · Helios Klinikum Berlin-Buch, Department of Obstetrics and Gynaecology, Berlin, Germany. · Department of Haematology-Oncology, National University Cancer Institute, Singapore. · Novartis Pharma SAS, Rueil Malmaison, France. · Novartis Pharma AG, Basel, Switzerland. · Kliniken Essen-Mitte, Essen, Germany. · Department of Internal Medicine I, Division of Oncology, Medical University of Vienna, Austria; Comprehensive Cancer Center Vienna, Austria. · Université Libre de Bruxelles, Institut Jules Rue Héger-Bordet 1, Medical Oncology Clinic, Belgium. · University Breast Centre of Franconia, OBGYN Department, University Hospital Erlangen, CCC Erlangen-EMN, Germany. · Breast International Group, Brussels, Belgium; Université Libre de Bruxelles, Institut Jules Rue Héger-Bordet 1, Medical Oncology Clinic, Belgium. · SOLTI Breast Cancer Research Group, Barcelona, Spain; Memorial Sloan-Kettering Cancer Center, New York, USA. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Australian New Zealand Breast Cancer Trials Group (ANZBCTG), Newcastle, Australia. Electronic address: · Pubmed 28923573
  • Hematology/Oncology Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Frontier Science (Scotland) Ltd., Kincraig, UK. · Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Radiation Oncology Department, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, MD, USA. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Department of Oncology, Division of Cancer, Oslo University Hospital, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Medical Oncology Unit, Azienda Istituti Ospitalieri, Cremona, Italy. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Case Western Reserve University, Cleveland, OH, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 28376188
  • WELBIO and Institute of Interdisciplinary Research (IRIBHM), Campus Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium · ULB-Cancer Research Center (U-CRC) Université Libre de Bruxelles, Brussels, Belgium. · WELBIO and Institute of Interdisciplinary Research (IRIBHM), Campus Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Laboratoire de Biologie Moléculaire du Gène, Faculté des Sciences, Université libre de Bruxelles (ULB), Brussels, Belgium. · Center for Microscopy and Molecular Imaging, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Tumor Bank of the Jules Bordet Institute, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Biobank of the Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · ULB-Cancer Research Center (U-CRC) Université Libre de Bruxelles, Brussels, Belgium · Pubmed 28566333
  • Medical Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. · Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands; Department of Radiology, University Medical Centre Utrecht, Utrecht, The Netherlands. · Department of Surgery, Haaglanden Medical Centre, The Hague, The Netherlands. · Department of Statistics, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Department of Product Development and Support, Agendia, Amsterdam, The Netherlands. · Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland; Ludwig Center for Cancer Research, University of Lausanne, Epalinges, Switzerland; Department of Oncology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland. · Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Surgery, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Amsterdam, The Netherlands. Electronic address: · Pubmed 28477490
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Prometheus Laboratories, San Diego, California. · Foundation Medicine, Cambridge, Massachusetts. · Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, North Carolina. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Department of Gynecology, University of Ulm, Ulm, Germany. · Novartis Pharmaceuticals, Basel, Switzerland. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Pubmed 28381415
  • Breast Data Centre, Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Institute for Oncology and Radiology of Serbia, National Cancer Research Centre, Belgrade, Republic of Serbia. · Breast International Group, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Hospital Albert Einstein, São Paulo, Brazil. · Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Pubmed 28151718
2016
  • a Breast International Group (BIG) , Brussels , Belgium. · b European Organization for Research and Treatment of Cancer (EORTC) , Brussels , Belgium. · c Institut Jules Bordet, Université Libre de Bruxelles , Brussels , Belgium. · Pubmed 27741402
  • European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium. · Breast International Group (BIG), Brussels, Belgium. · University of Illinois and College of Medicine, Department of Molecular and Integrative Physiology, IL, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 27643748
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium. Electronic address: · Pubmed 27430154
  • European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium. Electronic address: · European Centre for Disease Prevention and Control, Stockholm, Sweden. · European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium. · Breast Reconstruction Quality of Life Group, University of Bristol, Bristol, UK. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group, Brussels, Belgium. · Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Academic Medical Center, Amsterdam, Netherlands. · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Pubmed 27396647
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Department of Gynecology and Obstetrics, Ludwig-Maximilians-Universität, Munich, Germany. · Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Center of Experimental Medicine, Hamburg, Germany. · Circulating Biomarker Lab, SIRIC, Institut Curie, Paris, France. · Department of Medical Oncology, Institut Bergonié, Bordeaux, France. · Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna) and ACR-ITR VIEnna, Kaiser Franz Josef-Spital, Kundratstrasse 3, 1100 Vienna, Austria. · Medical and Scientific Affairs, F. Hoffmann-La Roche AG, Diagnostics Division, Basel, Switzerland. · European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium. · Breast International Group Headquarters, Brussels, Belgium. · Janssen Diagnostics LLC, NJ, USA. · Department of Gynecology and Obstetrics, Universitätsklinikum Ulm, Ulm, Germany. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Circulating Biomarker Lab, SIRIC, Institut Curie, Paris, France; Medical Oncology Department, Institut Curie, Université Paris Descartes, France. · Pubmed 27289552
  • Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group (BIG, aisbl), Brussels, Belgium. · Department of Medical Oncology, Hassan II University Hospital, Fez, Morocco. · Pubmed 26119941
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group (BIG aisbl), Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Medigene AG, Planegg, Germany. · Department of Biostatistics, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 27454930
  • Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Peninsula Oncology Centre, Melbourne, VIC, Australia. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · The Royal Marsden Hospital, London, UK. · Hospital Arnau de Vilanova, Lleida, Spain. · Sarah Cannon Research Institute, and Tennessee Oncology, Nashville, TN, USA. · Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic. · University of Alabama, Birmingham, AL, USA. · National University Hospital, Singapore. · Royal Melbourne Hospital, Parkville, VIC, Australia. · Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Herlev University Hospital, Copenhagen, Denmark. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Washington University School of Medicine, St Louis, MO, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Genentech, South San Francisco, CA, USA. · Barts Cancer Institute, Queen Mary University of London, London, UK. · Pubmed 27155741
  • EORTC-Headquarters, Medical Department, Brussels, Belgium. Electronic address: · Acıbadem Üniversitesi İç Hastalıkları/Tıbbi Onkoloji, Turkey. Electronic address: · EORTC-Headquarters, Statistical Department, Belgium. Electronic address: · Institute Bergonie, Bordeaux, France. Electronic address: · GZA Sint Augustinus, Antwerp, Belgium. Electronic address: · Ctr Becquerel-Rouen, France. Electronic address: · Radboudumc Nijmegen/Maastricht UMC+, Netherlands. Electronic address: · ZNA Middelheim, Belgium. Electronic address: · University Clinic Golnik, Slovenia. Electronic address: · Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. Electronic address: · NHS-Lothian, University of Edinburgh, Edinburgh, United Kingdom. Electronic address: · Pubmed 26724641
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast and Gynecological Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Avera Cancer Institute, Sioux Falls, South Dakota. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark11Department of Oncology, Odense University Hospital, Odense, Denmark12AgeCare, Odense University Hospital, Odense. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France14INSERM U1018, CESP, Université Paris-Sud, Villejuif France. · Pubmed 26633571
  • German Breast Group, Neu-Isenburg, Germany · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Surgery, Oncology and Gastroenterology, University of Padua, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · German Breast Group, Neu-Isenburg, Germany. · Frontier Science Scotland, Kincraig, UK. · Department of Medical Oncology, University of Verona, Verona, Italy. · Institute of Pathology, Charité Universitätsmedizin Berlin, and German Cancer Consortium (DKTK), Berlin. · Department of Obstetrics and Gynecology, University Hospital Kiel, Kiel, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussel, Belgium. · Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Obstetrics and Gynecology, Helios-Klinikum, Berlin-Buch, Germany. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 27177864
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
  • Unit of Biostatistics and Epidemiology, Gustave Roussy, Villejuif University Paris-Sud, University Paris-Saclay, UVSQ, CESP, INSERM, Villejuif Plateform Ligue nationale contre le cancer for meta-analyses in oncology, Gustave Roussy, Villejuif, France Institut Jules Bordet, Université Libre de Bruxelles, Brussels · Institut Jules Bordet, Université Libre de Bruxelles, Brussels Breast International Group (BIG), Brussels, Belgium. · Unit of Biostatistics and Epidemiology, Gustave Roussy, Villejuif. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany. · Department of Oncology, University of Edinburgh, Edinburgh, UK. · Rush University Medical Center, Chicago, USA. · Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Breast Unit, Royal Marsden Hospital, London, UK. · Scientific Direction, IRCCS National Cancer Research Centre "Giovanni Paolo II," Bari, Italy. · The Institute of Breast Oncology, Sheba Medical Center, Tel Hashomer, Israel. · Breast Cancer Diseases Unit and Department of Medical Oncology, Saint Louis Hospital, APHP, Paris, France. · German Breast Group, GBG ForschungsGmbH, Neu-Isenburg, Germany. · Department of Pathology, Centre Jean Perrin, EA 4233, University of Auvergne, Clermont-Ferrand, France. · Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles. · University of Miami School of Medicine, Comprehensive Cancer Research Group Inc, Columbia Cancer Research Network of Florida, Miami, USA. · IDDI, Louvain-la-Neuve, Hasselt University, Hasselt, Belgium. · Pubmed 26961151
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J. C. Heuson, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France. · Pubmed 26931736
  • Department of Medical Oncology, Institut Jules Bordet/Université libre de Bruxelles, 1 Rue Héger-Bordet, 1000 Bruxelles, Brussels, Belgium. · Department of Hematology and Oncology, Hôpital du Sacré-Cœur de Montréal/Université de Montréal, 5400 Boulevard Gouin, Montreal, Quebec H4J 1C5, Canada. · Pubmed 26787281
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue Yawkey, Boston, 1238, USA. · Department of Medical Oncology and Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK. · Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Royal Marsden Hospital, and Institute of Cancer Research, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Edinburgh Cancer Research Centre, Western general Hospital, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Department of Gynecology and Obstetrics and Multidisciplinary Breast Cancer Center, Helios Klinikum, Berlin-Buch, Germany. · Department of Gynecology and Obstetrics, Klinikum Off enbach, Off Enbach, Germany. · Department of Medical Oncology, The Andrew Love Cancer Centre, Deakin University, Geelong, Australia. · Department of Medical Oncology, San Raffaele Institute, Milan, Italy. · European Institute of Oncology, Milan, Italy. · Swiss Center for Breast Health, Sant'Anna Clinic, Lugano-Sorengo, Switzerland. · Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School, Boston, USA. · Pubmed 26708471
2015
  • Breast International Group (BIG, aisbl), Brussels, Belgium. · Breast European Adjuvant Studies Team (BrEAST), Brussels, Belgium. · Institut Jules Bordet, Université Libre des Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 26255196
  • Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Electronic address: · European Institute of Oncology, Division of Medical Oncology, Milan, Italy. · Department of Clinical Research, Institut Curie, Paris, France. · Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK, London Research Institute, London, UK. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breakthrough Breast Cancer Research Centre, Institute of Cancer Research and Kings College London School of Medicine, London, UK. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25840656
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 25712461
  • Department of Oncology, University Hospital Zurich, Zurich, Switzerland. Electronic address: · EORTC Headquarters, Brussels, Belgium. Electronic address: · Division of Medical Oncology, Second University of Naples, Naples, Italy. Electronic address: · KU Leuven - University of Leuven, Department of Oncology, Experimental Radiation Oncology, B-3000 Leuven, Belgium; University Hospitals Leuven, Department of Radiation Oncology, B-3000 Leuven, Belgium. Electronic address: · Medical University of Vienna, Vienna, Austria. Electronic address: · Institut de Cancérologie Gustave-Roussy, Villejuif, France; University Paris-Sud, Le Kremlin Bicêtre, Paris, France. Electronic address: · University of Dublin, Trinity College, Dublin, Ireland. Electronic address: · Université Paris Descartes, Paris, France. Electronic address: · Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. Electronic address: · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · VU Medical Center, Amsterdam, The Netherlands. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · University Hospitals Leuven and KU Leuven, Leuven, Belgium. Electronic address: · University Hospitals Leuven and KU Leuven, Leuven, Belgium. Electronic address: · Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: · Pubmed 25533737
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000 Brussels, Belgium. · Pubmed 25286972
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pathology Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital, Campus Mitte, German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland. · Pubmed 26358523
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · IRIBHM, Université Libre de Bruxelles (ULB), Route de Lennik, 808-1070 Brussels, Belgium. · Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK. · Department of Pathology, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Molecular Immunology Unit, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · Department of Medicine, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · Department of Genetics, Hôpital Erasme, Route de Lennik, 808-1070 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium; Department of Medicine, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. Electronic address: · IRIBHM, Université Libre de Bruxelles (ULB), Route de Lennik, 808-1070 Brussels, Belgium; WELBIO, Route de Lennik, 808-1070 Brussels, Belgium. Electronic address: · Pubmed 26440892
  • Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital Campus Mitte, and German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University, Hospital and Helsinki University, Helsinki, Finland. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Pathology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, University of Tampere and Tampere University Hospital, PO Box 607, FIN 33101, Tampere, Finland. · Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Pubmed 26234940
  • Department of Medical Oncology, National Institute of Oncology, Université Mohammed V de Rabat, Avenue Allal El Fassi, 10100, Rabat, Morocco. · Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000, Brussels, Belgium. · Department of Medical Oncology, National Institute of Oncology, Université Mohammed V de Rabat, Avenue Allal El Fassi, 10100, Rabat, Morocco. · Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000, Brussels, Belgium. · Pubmed 25971303
2014
  • BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25336696
  • 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Breast Cancer Translational Research Laboratory - J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory - J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. · Medical Oncology, Nepean Hospital, Penrith, NSW, Australia. · Breast International Group Executive Board. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium [3] Breast International Group Executive Board. · Pubmed 25225904
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. Electronic address: · Pubmed 25151406
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Department of Breast Medical Oncology, Multidisciplinary Breast Cancer Research Program, University of Texas MD Anderson Cancer Center, Houston, USA. · Institut de Cancérologie de l'Ouest, René Gauducheau, Centre de Recherche en Cancérologie, Nantes Saint Herblain, France. · Department of Medicine, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo. · Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. · Breast Cancer Centers, Memorial Cancer Institute, Hollywood. · Breast Oncology and Clinical Trials Education, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Oncologic Centre, AZ Nikolaas, Sint-Niklaas, Belgium. · Sarah Cannon Research Institute, Nashville, USA. · Centre des Maladies du Sein Deschênes-Fabia, CHU-Hôpital du Saint Sacrement, Québec, Canada. · Multidisciplinary Breast Centre and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Ironwood Cancer & Research Centers, Chandler. · Novartis Pharmaceuticals Corporation, East Hanover. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 25231953
  • Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France · European Organisation for Research and Treatment of Cancer (EORTC), Brussels. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France. · Centre George-François Leclerc, Dijon. · Ensemble Hospitalier de L'Institut Curie, Hopital René Huguenin, St-Cloud. · Centre Paul Strauss, Strasbourg. · Centre Val D'Aurelle-Paul Lamarque, Montpellier, France. · Medical University, Gdansk, Poland. · Centre Henri Becquerel, Rouen, France. · Geneva University Hospital, Geneva Swiss Group for Clinical Cancer Research (SAKK), Bern. · Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Institute of Oncology, Ljubljana University Clinic Golnik, Golnik, Slovenia. · Institut de Cancérologie de L'Ouest (ICO), Centre René Gauducheau, Nantes Centre Paul Papin, Angers. · Centre Alexis Vautrin, Nancy, France. · Department of Clinical Sciences, Lund University, Lund Skåne Department of Oncology, Skåne University Hospital, Lund. · Swedish Breast Cancer Group (SweBCG), Stockholm Department of Oncology, Karolinska Institutet, Radiumhemmet and Karolinska University Hospital, Stockholm, Sweden. · Cancer Services, Edinburgh University Anglo-Celtic Cooperative Oncology Group (ACCOG), Edinburgh, UK. · Pubmed 24618153
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. · Research Center of Epidemiology, Biostatistics and Clinical Research, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP598, Route de Lennik 808, 1070 Brussels, Belgium. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Department of Medical Oncology, Hirslanden Clinic Aarau, Schänisweg, 5001 Aarau, Switzerland. · Research Center of Social Approaches of Health, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP 596, Route de Lennik, 808, 1070 Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. Electronic address: · Pubmed 25446375
  • Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · OncoDNA, Gosselies, KU Leuven, Leuven. · Laboratory of Translational Genetics, KU Leuven, Leuven Vesalius Research Center, VIB, Leuven, Belgium. · Department of Biostatistic and Epidemiology, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Radiology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · Department of Pathology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels · Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels · Pubmed 25185240
2013
  • Author's Affiliation: Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24062313
2017
  • From the German Breast Group, Neu-Isenburg, Germany (G.M.); Frontier Science (Scotland), Kincraig, United Kingdom (M. Procter); the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), and Institut Jules Bordet, Université Libre de Bruxelles (M. Piccart) - all in Brussels; Roche Pharma (M.B., E.C., A.K.) and the Department of Cardiology, Cardio-Oncology, Bern University Hospital (T.S.) - both in Bern, Switzerland; the Department of Pathology, European Institute of Oncology, University of Milan, Milan (G.V.); the National Institute of Oncology, Budapest, Hungary (I.L.); Centre François Baclesse, Caen, France (C.L.); the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.A.Y.); Instituto Nacional de Câncer, Rio de Janeiro (J. Bines); Dana-Farber Cancer Institute, Harvard Medical School, Harvard T. H. Chan School of Public Health, and Frontier Science and Technology Research Foundation - all in Boston (R.D.G.); and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (J. Baselga). · Pubmed 28581356
2016
  • From Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal (F.C.); Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (L.J.V.); European Organization for Research and Treatment of Cancer Headquarters (J.B., L. Slaets, V.G., B.M., K.T.), Breast International Group Headquarters (T.G., C. Straehle), and Institut Jules Bordet, Université Libre de Bruxelles (C. Sotiriou, M.P.), Brussels, and Centre Hospitalier Universitaire Université Catholique de Louvain, Namur (P.V.) - both in Belgium; University of Milan and Istituto Europeo di Oncologia (G.V.) and Europa Donna-European Breast Cancer Coalition (S.K.), Milan, and Azienda Istituti Ospitalieri di Cremona, Cremona (R.P.) - both in Italy; Gustave Roussy, Villejuif (S.D., M.S.), Institut Curie Paris Sciences et Lettres, Université Paris Descartes, Sorbonne Paris Cité, Paris (J.-Y.P.). Institut Curie-Hôpital Rene Huguenin, Saint-Cloud (E.B.), and Centre Georges-Francois-Leclerc, Dijon (S.C.) - all in France; Swiss Institute of Bioinformatics and University of Lausanne, Lausanne, Switzerland (M.D.); Agendia (A.M.G., L. Stork) and the Netherlands Cancer Institute (R.B., E.R.), Amsterdam, Alrijne Ziekenhuis, Rijnland Leiderdorp (P.A.N.), Jeroen Bosch Hospital, 's-Hertogenbosch (T.J.S.), and Medisch Centrum Alkmaar, Alkmaar (J.M.H.) - all in the Netherlands; Institute of Oncology, Ljubljana, Slovenia (E.M.); Evangelisches Krankenhaus Bethesda, Duisburg, Germany (U.N.); University of Texas Health Sciences Center, San Antonio (P.R.); Hospital Universitario Vall d'Hebron, Barcelona (I.T.R.); Imperial College London, London (G.T.); and University of Texas M.D. Anderson Cancer Center, Houston (A.M.T.). · Pubmed 27557300
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
  • Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ; Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels; Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium; Hope S. Rugo, University of California, San Francisco; Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA; Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada; Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain; Thomas Bachelot, Centre Léon Bérard, Lyon, France; Shinzaburo Noguchi, Osaka University Medical School; Norikazu Masuda, Osaka National Hospital, Osaka, Japan; Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL; Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ; Shaker Dakhil, Cancer Center of Kansas, Wichita, KS; Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA; and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ; Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels; Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium; Hope S. Rugo, University of California, San Francisco; Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA; Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada; Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain; Thomas Bachelot, Centre Léon Bérard, Lyon, France; Shinzaburo Noguchi, Osaka University Medical School; Norikazu Masuda, Osaka National Hospital, Osaka, Japan; Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL; Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ; Shaker Dakhil, Cancer Center of Kansas, Wichita, KS; Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA; and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 26503204
2014
  • Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 25049332
  • Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium. · Pubmed 24667715
  • Department of Surgery and GROW School for Oncology and Developmental Biology (MM, MLS), Department of Surgery and Radiology (LMvR), Department of Medical Oncology, GROW School for Oncology and Developmental Biology (VCGTH), and Department of Epidemiology and GROW School for Oncology and Developmental Biology (ACV), Maastricht University Medical Center, Maastricht, the Netherlands; Department of Surgery, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands (LJAS); Division of Medical Oncology, Luzerner Kantonsspital, Lucerne, Switzerland (SA); Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian (DAC), Edinburgh Breast Unit (JMD), Western General Hospital, Edinburgh, UK; Cedars-Sinai Medical Center, Los Angeles, CA (AEG); Rutgers Cancer Institute of New Jersey, New Brunswick, NJ (BGH); Mater Centre Radiation Oncology Service, Princess Alexandra Hospital, Brisbane, Australia (BEH); Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center and Professor of Medicine, Weill Cornell Medical College, New York, NY (CAH); University of Arkansas for Medical Sciences, Winthrop P. Rockefeller Cancer Institute, Little Rock, AR (VSK); Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, Australia (BK); Interdisciplinary Breast Centre, Department of Gynaecology and Obstetrics, Klinikum Esslingen, Germany (TK); University of Miami Miller School of Medicine, Miami, FL (MEL); Radiation Oncology (BDS) and Department of Surgical Oncology, Division of Surgery (AL), University of Texas/MD Anderson Cancer Center, Houston, TX; Institut Jules Bordet, Université Libre de Bruxelles, Head of Medicine Department, Brussels, Belgium (MP); Surgery, University Medical Center, Leiden, the Netherlands (CJHvdV); Breast Service, Memorial Sloan-Kettering Cancer Center, Evelyn Lauder Breast Center, New York, NY(KJVZ); Antwerp University Hospital, Department of Medical Oncology, Edegem, Belgium (JBV); Department of Pathology, European Institute of · Pubmed 25381395
  • Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumDepartment of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxel · Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 24825746
2013
  • From the Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Edinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, United Kingdom; and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Pubmed 23714441
  • Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Pubmed 23459626
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23990869
  • Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY; James G. Greger Jr, GlaxoSmithKline, Collegeville, PA; Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles; Phuong Dinh, Breast International Group, Brussels; Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium; Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland; Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research, London, United Kingdom; Serena Di Cosimo, IRCCS Fondazione Instituto Nazionale dei Tumori, Milan, Italy; Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain; Christian Jackisch, Kilinikum Offenbach, Offenbach; Bahriye Aktas, Kliniken Essen-Mitte, Evang, Essen; Holger Eidtmann, University Hospital Kiel, Kiel, Germany; Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; Chiun-Sheng Huang, National Taiwan University Hospital; Ruey Kuen Hsieh, Mackey Memorial Hospital, Taipei, Taiwan; and Lydia Dreosti, University of Pretoria, Pretoria, South Africa. · Pubmed 24248687
  • Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24092940
  • Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23778140
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23739063
  • Breast Cancer Translational Research Laboratory, JC Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23638089
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23169515
  • Breast Cancer Translation Research Laboratory J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23028037
2012
  • Breast Cancer Translational Research Laboratory, Faculty of Medicine, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Pubmed 22652232
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22508827
  • Breast Cancer Translational Research Laboratory (BCTL) J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22261811
2011
  • Breast Cancer Translational Research Laboratory, Faculty of Medicine, Université Libre de Bruxelles, Institut Jules Bordet, Bruxelles 1000, Belgium. · Pubmed 22043058
  • Laboratory of Cancer Epigenetics, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 21910250
  • Translational Research Unit, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 21738599
  • Department of Medical Oncology, Institut Jules Bordet, Universite Libre de Bruxelles, 1000 Brussels, Belgium. · Pubmed 21354372
2009
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 19289395
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 125 total) written by Martine J. Piccart about Breast Neoplasms:

  • Treatment of advanced HER2-positive breast cancer: 2018 and beyond. 2018
  • 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3). 2017
  • 3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). 2017
  • Recurrence dynamics of breast cancer according to baseline body mass index. 2017
  • Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE). 2017
  • Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer. 2017
  • Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial. 2017
  • CDK4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclib. 2017
  • Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial. 2017
  • HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2. 2017
Show List of Full Article Records
Google Searches

Learn more about Martine J. Piccart using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous cities in Belgium
Jules Bordet Institute
Universite Libre de Bruxelles
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous cities in Belgium
2018
  • Academic Promoting Team, Institut Jules Bordet, Blvd de Waterloo 121, 7th Floor., 1000 Brussels, Belgium. Electronic address: · Academic Promoting Team, Institut Jules Bordet, Belgium. · Medical Department, Institut Jules Bordet, Belgium. · Medical Oncology Department, University Hospital Leuven, Belgium. · Research Department, Institut Jules Bordet, Belgium. · Pubmed 29751334
Jules Bordet Institute
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA. · Indiana University Medical CTR, Indianapolis, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Pubmed 27927580
  • Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. Electronic address: · Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, 4000 Liège, Belgium. · Centre Hospitalier de Luxembourg, 1210 Luxembour, GD Luxembourg, Belgium. · Department of Radiotherapy, CHU Liège, 4000 Liège, Belgium. · Department of Internal Medicine and Oncology, Clinique St-Joseph Espérance, 4000 Liège, Belgium. · Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, 59100 Prato, Italy. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 29096156
  • Hematology/Oncology Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Frontier Science (Scotland) Ltd., Kincraig, UK. · Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Radiation Oncology Department, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, MD, USA. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Department of Oncology, Division of Cancer, Oslo University Hospital, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Medical Oncology Unit, Azienda Istituti Ospitalieri, Cremona, Italy. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Case Western Reserve University, Cleveland, OH, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 28376188
  • WELBIO and Institute of Interdisciplinary Research (IRIBHM), Campus Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium · ULB-Cancer Research Center (U-CRC) Université Libre de Bruxelles, Brussels, Belgium. · WELBIO and Institute of Interdisciplinary Research (IRIBHM), Campus Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Laboratoire de Biologie Moléculaire du Gène, Faculté des Sciences, Université libre de Bruxelles (ULB), Brussels, Belgium. · Center for Microscopy and Molecular Imaging, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Tumor Bank of the Jules Bordet Institute, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Biobank of the Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · ULB-Cancer Research Center (U-CRC) Université Libre de Bruxelles, Brussels, Belgium · Pubmed 28566333
  • Medical Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. · Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands; Department of Radiology, University Medical Centre Utrecht, Utrecht, The Netherlands. · Department of Surgery, Haaglanden Medical Centre, The Hague, The Netherlands. · Department of Statistics, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Department of Product Development and Support, Agendia, Amsterdam, The Netherlands. · Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland; Ludwig Center for Cancer Research, University of Lausanne, Epalinges, Switzerland; Department of Oncology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland. · Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Surgery, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Amsterdam, The Netherlands. Electronic address: · Pubmed 28477490
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Prometheus Laboratories, San Diego, California. · Foundation Medicine, Cambridge, Massachusetts. · Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, North Carolina. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Department of Gynecology, University of Ulm, Ulm, Germany. · Novartis Pharmaceuticals, Basel, Switzerland. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Pubmed 28381415
  • Breast Data Centre, Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Institute for Oncology and Radiology of Serbia, National Cancer Research Centre, Belgrade, Republic of Serbia. · Breast International Group, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Hospital Albert Einstein, São Paulo, Brazil. · Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Pubmed 28151718
2016
  • a Breast International Group (BIG) , Brussels , Belgium. · b European Organization for Research and Treatment of Cancer (EORTC) , Brussels , Belgium. · c Institut Jules Bordet, Université Libre de Bruxelles , Brussels , Belgium. · Pubmed 27741402
  • European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium. · Breast International Group (BIG), Brussels, Belgium. · University of Illinois and College of Medicine, Department of Molecular and Integrative Physiology, IL, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 27643748
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium. Electronic address: · Pubmed 27430154
  • European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium. Electronic address: · European Centre for Disease Prevention and Control, Stockholm, Sweden. · European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium. · Breast Reconstruction Quality of Life Group, University of Bristol, Bristol, UK. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group, Brussels, Belgium. · Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Academic Medical Center, Amsterdam, Netherlands. · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Pubmed 27396647
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Department of Gynecology and Obstetrics, Ludwig-Maximilians-Universität, Munich, Germany. · Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Center of Experimental Medicine, Hamburg, Germany. · Circulating Biomarker Lab, SIRIC, Institut Curie, Paris, France. · Department of Medical Oncology, Institut Bergonié, Bordeaux, France. · Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna) and ACR-ITR VIEnna, Kaiser Franz Josef-Spital, Kundratstrasse 3, 1100 Vienna, Austria. · Medical and Scientific Affairs, F. Hoffmann-La Roche AG, Diagnostics Division, Basel, Switzerland. · European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium. · Breast International Group Headquarters, Brussels, Belgium. · Janssen Diagnostics LLC, NJ, USA. · Department of Gynecology and Obstetrics, Universitätsklinikum Ulm, Ulm, Germany. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Circulating Biomarker Lab, SIRIC, Institut Curie, Paris, France; Medical Oncology Department, Institut Curie, Université Paris Descartes, France. · Pubmed 27289552
  • Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group (BIG, aisbl), Brussels, Belgium. · Department of Medical Oncology, Hassan II University Hospital, Fez, Morocco. · Pubmed 26119941
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group (BIG aisbl), Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Medigene AG, Planegg, Germany. · Department of Biostatistics, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 27454930
  • Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Peninsula Oncology Centre, Melbourne, VIC, Australia. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · The Royal Marsden Hospital, London, UK. · Hospital Arnau de Vilanova, Lleida, Spain. · Sarah Cannon Research Institute, and Tennessee Oncology, Nashville, TN, USA. · Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic. · University of Alabama, Birmingham, AL, USA. · National University Hospital, Singapore. · Royal Melbourne Hospital, Parkville, VIC, Australia. · Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Herlev University Hospital, Copenhagen, Denmark. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Washington University School of Medicine, St Louis, MO, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Genentech, South San Francisco, CA, USA. · Barts Cancer Institute, Queen Mary University of London, London, UK. · Pubmed 27155741
  • EORTC-Headquarters, Medical Department, Brussels, Belgium. Electronic address: · Acıbadem Üniversitesi İç Hastalıkları/Tıbbi Onkoloji, Turkey. Electronic address: · EORTC-Headquarters, Statistical Department, Belgium. Electronic address: · Institute Bergonie, Bordeaux, France. Electronic address: · GZA Sint Augustinus, Antwerp, Belgium. Electronic address: · Ctr Becquerel-Rouen, France. Electronic address: · Radboudumc Nijmegen/Maastricht UMC+, Netherlands. Electronic address: · ZNA Middelheim, Belgium. Electronic address: · University Clinic Golnik, Slovenia. Electronic address: · Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. Electronic address: · NHS-Lothian, University of Edinburgh, Edinburgh, United Kingdom. Electronic address: · Pubmed 26724641
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast and Gynecological Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Avera Cancer Institute, Sioux Falls, South Dakota. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark11Department of Oncology, Odense University Hospital, Odense, Denmark12AgeCare, Odense University Hospital, Odense. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France14INSERM U1018, CESP, Université Paris-Sud, Villejuif France. · Pubmed 26633571
  • German Breast Group, Neu-Isenburg, Germany · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Surgery, Oncology and Gastroenterology, University of Padua, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · German Breast Group, Neu-Isenburg, Germany. · Frontier Science Scotland, Kincraig, UK. · Department of Medical Oncology, University of Verona, Verona, Italy. · Institute of Pathology, Charité Universitätsmedizin Berlin, and German Cancer Consortium (DKTK), Berlin. · Department of Obstetrics and Gynecology, University Hospital Kiel, Kiel, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussel, Belgium. · Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Obstetrics and Gynecology, Helios-Klinikum, Berlin-Buch, Germany. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 27177864
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
  • Unit of Biostatistics and Epidemiology, Gustave Roussy, Villejuif University Paris-Sud, University Paris-Saclay, UVSQ, CESP, INSERM, Villejuif Plateform Ligue nationale contre le cancer for meta-analyses in oncology, Gustave Roussy, Villejuif, France Institut Jules Bordet, Université Libre de Bruxelles, Brussels · Institut Jules Bordet, Université Libre de Bruxelles, Brussels Breast International Group (BIG), Brussels, Belgium. · Unit of Biostatistics and Epidemiology, Gustave Roussy, Villejuif. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany. · Department of Oncology, University of Edinburgh, Edinburgh, UK. · Rush University Medical Center, Chicago, USA. · Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Breast Unit, Royal Marsden Hospital, London, UK. · Scientific Direction, IRCCS National Cancer Research Centre "Giovanni Paolo II," Bari, Italy. · The Institute of Breast Oncology, Sheba Medical Center, Tel Hashomer, Israel. · Breast Cancer Diseases Unit and Department of Medical Oncology, Saint Louis Hospital, APHP, Paris, France. · German Breast Group, GBG ForschungsGmbH, Neu-Isenburg, Germany. · Department of Pathology, Centre Jean Perrin, EA 4233, University of Auvergne, Clermont-Ferrand, France. · Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles. · University of Miami School of Medicine, Comprehensive Cancer Research Group Inc, Columbia Cancer Research Network of Florida, Miami, USA. · IDDI, Louvain-la-Neuve, Hasselt University, Hasselt, Belgium. · Pubmed 26961151
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J. C. Heuson, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France. · Pubmed 26931736
  • Department of Medical Oncology, Institut Jules Bordet/Université libre de Bruxelles, 1 Rue Héger-Bordet, 1000 Bruxelles, Brussels, Belgium. · Department of Hematology and Oncology, Hôpital du Sacré-Cœur de Montréal/Université de Montréal, 5400 Boulevard Gouin, Montreal, Quebec H4J 1C5, Canada. · Pubmed 26787281
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue Yawkey, Boston, 1238, USA. · Department of Medical Oncology and Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK. · Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Royal Marsden Hospital, and Institute of Cancer Research, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Edinburgh Cancer Research Centre, Western general Hospital, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Department of Gynecology and Obstetrics and Multidisciplinary Breast Cancer Center, Helios Klinikum, Berlin-Buch, Germany. · Department of Gynecology and Obstetrics, Klinikum Off enbach, Off Enbach, Germany. · Department of Medical Oncology, The Andrew Love Cancer Centre, Deakin University, Geelong, Australia. · Department of Medical Oncology, San Raffaele Institute, Milan, Italy. · European Institute of Oncology, Milan, Italy. · Swiss Center for Breast Health, Sant'Anna Clinic, Lugano-Sorengo, Switzerland. · Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School, Boston, USA. · Pubmed 26708471
  • Laboratory of Molecular and Medical Oncology, Vrije Universiteit Brussel, Brussels, Belgium. · Department of Medical Oncology, Oncologisch Centrum, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Jules Bordet Institute, Brussels, Belgium. · Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium. · Pubmed 26010302
  • University of California, San Francisco, San Francisco, CA · Netherlands Cancer Institute, Amsterdam, the Netherlands · Institut Jules Bordet, Brussels, Belgium · Pubmed 27959762
2015
  • Breast International Group (BIG, aisbl), Brussels, Belgium. · Breast European Adjuvant Studies Team (BrEAST), Brussels, Belgium. · Institut Jules Bordet, Université Libre des Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 26255196
  • Breast International Group (BIG)-aisbl c/o Jules Bordet Institute, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · University College London Cancer Institute, Cancer Research UK Lung Cancer Centre of Excellence, Paul O'Gorman Building, Huntley Street, London WC1E 6DD, UK. · Jules Bordet Institute, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Pubmed 25895611
  • Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Electronic address: · European Institute of Oncology, Division of Medical Oncology, Milan, Italy. · Department of Clinical Research, Institut Curie, Paris, France. · Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK, London Research Institute, London, UK. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breakthrough Breast Cancer Research Centre, Institute of Cancer Research and Kings College London School of Medicine, London, UK. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25840656
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 25712461
  • Department of Oncology, University Hospital Zurich, Zurich, Switzerland. Electronic address: · EORTC Headquarters, Brussels, Belgium. Electronic address: · Division of Medical Oncology, Second University of Naples, Naples, Italy. Electronic address: · KU Leuven - University of Leuven, Department of Oncology, Experimental Radiation Oncology, B-3000 Leuven, Belgium; University Hospitals Leuven, Department of Radiation Oncology, B-3000 Leuven, Belgium. Electronic address: · Medical University of Vienna, Vienna, Austria. Electronic address: · Institut de Cancérologie Gustave-Roussy, Villejuif, France; University Paris-Sud, Le Kremlin Bicêtre, Paris, France. Electronic address: · University of Dublin, Trinity College, Dublin, Ireland. Electronic address: · Université Paris Descartes, Paris, France. Electronic address: · Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. Electronic address: · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · VU Medical Center, Amsterdam, The Netherlands. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · University Hospitals Leuven and KU Leuven, Leuven, Belgium. Electronic address: · University Hospitals Leuven and KU Leuven, Leuven, Belgium. Electronic address: · Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: · Pubmed 25533737
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000 Brussels, Belgium. · Pubmed 25286972
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pathology Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital, Campus Mitte, German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland. · Pubmed 26358523
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · IRIBHM, Université Libre de Bruxelles (ULB), Route de Lennik, 808-1070 Brussels, Belgium. · Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK. · Department of Pathology, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Molecular Immunology Unit, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · Department of Medicine, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · Department of Genetics, Hôpital Erasme, Route de Lennik, 808-1070 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium; Department of Medicine, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. Electronic address: · IRIBHM, Université Libre de Bruxelles (ULB), Route de Lennik, 808-1070 Brussels, Belgium; WELBIO, Route de Lennik, 808-1070 Brussels, Belgium. Electronic address: · Pubmed 26440892
  • Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital Campus Mitte, and German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University, Hospital and Helsinki University, Helsinki, Finland. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Pathology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, University of Tampere and Tampere University Hospital, PO Box 607, FIN 33101, Tampere, Finland. · Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Pubmed 26234940
  • Department of Medical Oncology, National Institute of Oncology, Université Mohammed V de Rabat, Avenue Allal El Fassi, 10100, Rabat, Morocco. · Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000, Brussels, Belgium. · Department of Medical Oncology, National Institute of Oncology, Université Mohammed V de Rabat, Avenue Allal El Fassi, 10100, Rabat, Morocco. · Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000, Brussels, Belgium. · Pubmed 25971303
  • Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumouri (IRST) - IRCCS, Meldola, Italy. · Department of Internal Medicine, University of Genoa and IRCCS Azienda Ospedaliera Universitaria San Martino - IST, Genoa, Italy. · Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, UK. · Translational Breast Cancer Genomics Lab, Division of Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · VIB Vesalius Research Center, KU Leuven, Campus Gasthuisberg, Herestraat 49, Bus 912, Leuven, Belgium. · Pathology Unit, 'G.B. Morgagni-L. Pierantoni' Hospital, Forlì, Italy. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Pathology Department, Jules Bordet Institute, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Medical Oncology, Jules Bordet Institute, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Haematology, University of Cambridge, Cambridge, UK. · Department of Haematology, Addenbrooke's Hospital, Cambridge, UK. · Pubmed 25850943
  • Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science (Scotland) Ltd., Inverness-shire, Scotland. · Clinical Research, Monogram Biosciences, Inc., South San Francisco, California. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Center, Department of Obstetrics and Gynecology, and CCC LMU, University of Munich, Munich, Germany. · Genetics and Genomics Program, Yale School of Medicine, New Haven, Connecticut. · Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania. · Department of Gynecology and Midwifery, University Hospital Kiel, Kiel, Germany. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Jules Bordet Institute, Brussels, Belgium. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 25467182
2014
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, Arome, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, DE, USA. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · Advanced BC.org, New York, USA. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25244983
  • BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25336696
  • 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Breast Cancer Translational Research Laboratory - J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory - J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. · Medical Oncology, Nepean Hospital, Penrith, NSW, Australia. · Breast International Group Executive Board. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium [3] Breast International Group Executive Board. · Pubmed 25225904
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. Electronic address: · Pubmed 25151406
  • US Food and Drug Administration, Silver Spring, MD, USA. Electronic address: · US Food and Drug Administration, Silver Spring, MD, USA. · HELIOS Klinikum, Berlin, Germany. · German Breast Group, Neu-Isenburg, Germany. · National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA. · Institut Bergonié INSERM U916 and Université Bordeaux Segalen, Bordeaux, France. · Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian, UK. · San Raffaele Scientific Institute, Milan, Italy. · Fondazione Michelangelo, Milan, Italy. · Medstar Washington Hospital Center, Washington, DC, USA. · EORTC Headquarters, Brussels, Belgium. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · St Gertrauden Hospital, Berlin, Germany. · MD Anderson Cancer Center Orlando, Orlando, FL, USA. · KarolinskaInstitutet and University Hospital, Stockholm, Sweden. · NN Petrov Research Institute of Oncology, St Petersburg, Russia. · University Women's Hospital, Kiel, Germany. · Jules Bordet Institute, Brussels, Belgium. · Frauenklinik des Universitätsklinikums, Erlangen, Germany. · Universitäts Frauenklinik, Rostock, Germany. · Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · Hospital of the Ludwig Maximilian University of Munich, Munich, Germany. · Pubmed 24529560
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Department of Breast Medical Oncology, Multidisciplinary Breast Cancer Research Program, University of Texas MD Anderson Cancer Center, Houston, USA. · Institut de Cancérologie de l'Ouest, René Gauducheau, Centre de Recherche en Cancérologie, Nantes Saint Herblain, France. · Department of Medicine, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo. · Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. · Breast Cancer Centers, Memorial Cancer Institute, Hollywood. · Breast Oncology and Clinical Trials Education, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Oncologic Centre, AZ Nikolaas, Sint-Niklaas, Belgium. · Sarah Cannon Research Institute, Nashville, USA. · Centre des Maladies du Sein Deschênes-Fabia, CHU-Hôpital du Saint Sacrement, Québec, Canada. · Multidisciplinary Breast Centre and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Ironwood Cancer & Research Centers, Chandler. · Novartis Pharmaceuticals Corporation, East Hanover. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 25231953
  • Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France · European Organisation for Research and Treatment of Cancer (EORTC), Brussels. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France. · Centre George-François Leclerc, Dijon. · Ensemble Hospitalier de L'Institut Curie, Hopital René Huguenin, St-Cloud. · Centre Paul Strauss, Strasbourg. · Centre Val D'Aurelle-Paul Lamarque, Montpellier, France. · Medical University, Gdansk, Poland. · Centre Henri Becquerel, Rouen, France. · Geneva University Hospital, Geneva Swiss Group for Clinical Cancer Research (SAKK), Bern. · Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Institute of Oncology, Ljubljana University Clinic Golnik, Golnik, Slovenia. · Institut de Cancérologie de L'Ouest (ICO), Centre René Gauducheau, Nantes Centre Paul Papin, Angers. · Centre Alexis Vautrin, Nancy, France. · Department of Clinical Sciences, Lund University, Lund Skåne Department of Oncology, Skåne University Hospital, Lund. · Swedish Breast Cancer Group (SweBCG), Stockholm Department of Oncology, Karolinska Institutet, Radiumhemmet and Karolinska University Hospital, Stockholm, Sweden. · Cancer Services, Edinburgh University Anglo-Celtic Cooperative Oncology Group (ACCOG), Edinburgh, UK. · Pubmed 24618153
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. · Research Center of Epidemiology, Biostatistics and Clinical Research, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP598, Route de Lennik 808, 1070 Brussels, Belgium. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Department of Medical Oncology, Hirslanden Clinic Aarau, Schänisweg, 5001 Aarau, Switzerland. · Research Center of Social Approaches of Health, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP 596, Route de Lennik, 808, 1070 Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. Electronic address: · Pubmed 25446375
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal · European School of Oncology, Milan, Italy European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, Denmark. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · AdvancedBC.org, New York. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25234545
  • Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · OncoDNA, Gosselies, KU Leuven, Leuven. · Laboratory of Translational Genetics, KU Leuven, Leuven Vesalius Research Center, VIB, Leuven, Belgium. · Department of Biostatistic and Epidemiology, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Radiology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · Department of Pathology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels · Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels · Pubmed 25185240
  • Breast Data Center, Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium; Medical Oncology Department, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, Serbia. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Pathological Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Department of Medical Oncology, "Sandro Pitigliani" Hospital of Prato, Prato, Italy. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, Boulevard de Waterloo 125, Brussels, Belgium; Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. Electronic address: · Pubmed 24768477
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne,Australia · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Service de Biostatistique et D'Epidemiology, Gustave Roussy, Universite Paris-Sud, Villejuif, France. · Department of Anatomical Pathology, Institut Jules Bordet, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, Tampere University Hospital, Tampere. · Department of Oncology, Helsinki University Central Hospital, Helsinki. · Cancer Center, Kuopio University Hospital, Kuopio, Finland. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · German Breast Group, Neu-Isenburg. · Charité University Hospital, Institute of Pathology, Berlin, Germany. · Immunology in Cancer and Infection Laboratory, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute; School of Medicine, University of Queensland, Herston, Australia. · Pubmed 24608200
  • Department of Medical Oncology, Institut Jules Bordet, Brussels. · Data Centre, Institut Jules Bordet, Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Brussels · Pubmed 24562450
2013
  • Author's Affiliation: Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24062313
2017
  • From the German Breast Group, Neu-Isenburg, Germany (G.M.); Frontier Science (Scotland), Kincraig, United Kingdom (M. Procter); the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), and Institut Jules Bordet, Université Libre de Bruxelles (M. Piccart) - all in Brussels; Roche Pharma (M.B., E.C., A.K.) and the Department of Cardiology, Cardio-Oncology, Bern University Hospital (T.S.) - both in Bern, Switzerland; the Department of Pathology, European Institute of Oncology, University of Milan, Milan (G.V.); the National Institute of Oncology, Budapest, Hungary (I.L.); Centre François Baclesse, Caen, France (C.L.); the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.A.Y.); Instituto Nacional de Câncer, Rio de Janeiro (J. Bines); Dana-Farber Cancer Institute, Harvard Medical School, Harvard T. H. Chan School of Public Health, and Frontier Science and Technology Research Foundation - all in Boston (R.D.G.); and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (J. Baselga). · Pubmed 28581356
2016
  • From Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal (F.C.); Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (L.J.V.); European Organization for Research and Treatment of Cancer Headquarters (J.B., L. Slaets, V.G., B.M., K.T.), Breast International Group Headquarters (T.G., C. Straehle), and Institut Jules Bordet, Université Libre de Bruxelles (C. Sotiriou, M.P.), Brussels, and Centre Hospitalier Universitaire Université Catholique de Louvain, Namur (P.V.) - both in Belgium; University of Milan and Istituto Europeo di Oncologia (G.V.) and Europa Donna-European Breast Cancer Coalition (S.K.), Milan, and Azienda Istituti Ospitalieri di Cremona, Cremona (R.P.) - both in Italy; Gustave Roussy, Villejuif (S.D., M.S.), Institut Curie Paris Sciences et Lettres, Université Paris Descartes, Sorbonne Paris Cité, Paris (J.-Y.P.). Institut Curie-Hôpital Rene Huguenin, Saint-Cloud (E.B.), and Centre Georges-Francois-Leclerc, Dijon (S.C.) - all in France; Swiss Institute of Bioinformatics and University of Lausanne, Lausanne, Switzerland (M.D.); Agendia (A.M.G., L. Stork) and the Netherlands Cancer Institute (R.B., E.R.), Amsterdam, Alrijne Ziekenhuis, Rijnland Leiderdorp (P.A.N.), Jeroen Bosch Hospital, 's-Hertogenbosch (T.J.S.), and Medisch Centrum Alkmaar, Alkmaar (J.M.H.) - all in the Netherlands; Institute of Oncology, Ljubljana, Slovenia (E.M.); Evangelisches Krankenhaus Bethesda, Duisburg, Germany (U.N.); University of Texas Health Sciences Center, San Antonio (P.R.); Hospital Universitario Vall d'Hebron, Barcelona (I.T.R.); Imperial College London, London (G.T.); and University of Texas M.D. Anderson Cancer Center, Houston (A.M.T.). · Pubmed 27557300
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
2015
  • Breast International Group Headquarters (BIG-aisbl), Brussels 1000, Belgium; email: , · Pubmed 25386936
2014
  • Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 25049332
  • Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium. · Pubmed 24667715
  • Breast Cancer Translational Research Laboratory (BCTL), Institut Jules Bordet, Brussels, Belgium. · Pubmed 25412710
  • Department of Surgery and GROW School for Oncology and Developmental Biology (MM, MLS), Department of Surgery and Radiology (LMvR), Department of Medical Oncology, GROW School for Oncology and Developmental Biology (VCGTH), and Department of Epidemiology and GROW School for Oncology and Developmental Biology (ACV), Maastricht University Medical Center, Maastricht, the Netherlands; Department of Surgery, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands (LJAS); Division of Medical Oncology, Luzerner Kantonsspital, Lucerne, Switzerland (SA); Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian (DAC), Edinburgh Breast Unit (JMD), Western General Hospital, Edinburgh, UK; Cedars-Sinai Medical Center, Los Angeles, CA (AEG); Rutgers Cancer Institute of New Jersey, New Brunswick, NJ (BGH); Mater Centre Radiation Oncology Service, Princess Alexandra Hospital, Brisbane, Australia (BEH); Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center and Professor of Medicine, Weill Cornell Medical College, New York, NY (CAH); University of Arkansas for Medical Sciences, Winthrop P. Rockefeller Cancer Institute, Little Rock, AR (VSK); Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, Australia (BK); Interdisciplinary Breast Centre, Department of Gynaecology and Obstetrics, Klinikum Esslingen, Germany (TK); University of Miami Miller School of Medicine, Miami, FL (MEL); Radiation Oncology (BDS) and Department of Surgical Oncology, Division of Surgery (AL), University of Texas/MD Anderson Cancer Center, Houston, TX; Institut Jules Bordet, Université Libre de Bruxelles, Head of Medicine Department, Brussels, Belgium (MP); Surgery, University Medical Center, Leiden, the Netherlands (CJHvdV); Breast Service, Memorial Sloan-Kettering Cancer Center, Evelyn Lauder Breast Center, New York, NY(KJVZ); Antwerp University Hospital, Department of Medical Oncology, Edegem, Belgium (JBV); Department of Pathology, European Institute of · Pubmed 25381395
  • Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumDepartment of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxel · Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 24825746
2013
  • From the Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Edinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, United Kingdom; and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Pubmed 23714441
  • Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Pubmed 23459626
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23990869
  • Breast Cancer Translational Research Laboratory (BCTL) J.C. Heuson, Institut Jules Bordet, Blvd de Waterloo, 125, 1000 Brussels, Belgium. · Pubmed 23341518
  • Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY; James G. Greger Jr, GlaxoSmithKline, Collegeville, PA; Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles; Phuong Dinh, Breast International Group, Brussels; Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium; Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland; Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research, London, United Kingdom; Serena Di Cosimo, IRCCS Fondazione Instituto Nazionale dei Tumori, Milan, Italy; Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain; Christian Jackisch, Kilinikum Offenbach, Offenbach; Bahriye Aktas, Kliniken Essen-Mitte, Evang, Essen; Holger Eidtmann, University Hospital Kiel, Kiel, Germany; Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; Chiun-Sheng Huang, National Taiwan University Hospital; Ruey Kuen Hsieh, Mackey Memorial Hospital, Taipei, Taiwan; and Lydia Dreosti, University of Pretoria, Pretoria, South Africa. · Pubmed 24248687
  • Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24092940
  • Institut Jules Bordet, Boulevard de Waterloo, 125, 1000 Brussels, Belgium. · Pubmed 23902243
  • Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23778140
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23739063
  • Breast Cancer Translational Research Laboratory, JC Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23638089
  • Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Brussels, Belgium. · Pubmed 23301057
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23169515
  • Breast Cancer Translation Research Laboratory J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23028037
2012
  • Breast Cancer Translational Research Laboratory, Faculty of Medicine, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Pubmed 22652232
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22508827
  • Breast Cancer Translational Research Laboratory (BCTL) J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22261811
  • Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, 125 Bld de Waterloo, Brussels 1000, Belgium. · Pubmed 22235100
2011
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, L'Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 21918439
  • Department of Medical Oncology, Jules Bordet Institute, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Pubmed 21342046
  • Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium. · Pubmed 21289366
  • Breast Cancer Translational Research Laboratory, Faculty of Medicine, Université Libre de Bruxelles, Institut Jules Bordet, Bruxelles 1000, Belgium. · Pubmed 22043058
  • Translational Research Unit, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 21738599
  • Department of Medical Oncology, Institut Jules Bordet, Universite Libre de Bruxelles, 1000 Brussels, Belgium. · Pubmed 21354372
  • Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. · Pubmed 21264346
2010
  • Jules Bordet Institute, Department of Medical Oncology, Boulevard Waterloo, 121,1000 Brussels, Belgium. · Pubmed 20735311
  • Breast Cancer Translational Research Laboratory JC Heuson, Jules Bordet Institute, Brussels, Belgium. · Pubmed 20856894
  • Department of Research, Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, East Melbourne 3002, Australia. · Pubmed 20479250
  • Functional Genomics and Translational Research Unit, Medical Oncology Department, Jules Bordet Institute, Boulevard de Waterloo, Brussels, 1000, Belgium. · Pubmed 20156340
2009
  • Translational Research Unit, Jules Bordet Institute, Brussels, Belgium. · Pubmed 19744330
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 19289395
Universite Libre de Bruxelles
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA. · Indiana University Medical CTR, Indianapolis, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Pubmed 27927580
  • Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. Electronic address: · Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, 4000 Liège, Belgium. · Centre Hospitalier de Luxembourg, 1210 Luxembour, GD Luxembourg, Belgium. · Department of Radiotherapy, CHU Liège, 4000 Liège, Belgium. · Department of Internal Medicine and Oncology, Clinique St-Joseph Espérance, 4000 Liège, Belgium. · Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, 59100 Prato, Italy. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 29096156
  • German Breast Group, Neu-Isenburg, Germany; Sana-Klinikum Offenbach, Germany. Electronic address: · SOLTI Breast Cancer Research Group, Barcelona, Spain. · German Breast Group, Neu-Isenburg, Germany. · Breast International Group, Brussels, Belgium. · Gustave Roussy, Service de Biostatistique et d'Epidémiologie, Villejuif, France; CESP, Inserm U1018, Univ. Paris Sud, Univ. Paris-Saclay, Villejuif, France. · Institute of Pathology, Charité University Hospital, Berlin, Germany. · Luisenkrankenhaus Düsseldorf, Germany. · Hospital Clinico Universitario de Valencia, Spain. · Helios Klinikum Berlin-Buch, Department of Obstetrics and Gynaecology, Berlin, Germany. · Department of Haematology-Oncology, National University Cancer Institute, Singapore. · Novartis Pharma SAS, Rueil Malmaison, France. · Novartis Pharma AG, Basel, Switzerland. · Kliniken Essen-Mitte, Essen, Germany. · Department of Internal Medicine I, Division of Oncology, Medical University of Vienna, Austria; Comprehensive Cancer Center Vienna, Austria. · Université Libre de Bruxelles, Institut Jules Rue Héger-Bordet 1, Medical Oncology Clinic, Belgium. · University Breast Centre of Franconia, OBGYN Department, University Hospital Erlangen, CCC Erlangen-EMN, Germany. · Breast International Group, Brussels, Belgium; Université Libre de Bruxelles, Institut Jules Rue Héger-Bordet 1, Medical Oncology Clinic, Belgium. · SOLTI Breast Cancer Research Group, Barcelona, Spain; Memorial Sloan-Kettering Cancer Center, New York, USA. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Australian New Zealand Breast Cancer Trials Group (ANZBCTG), Newcastle, Australia. Electronic address: · Pubmed 28923573
  • Hematology/Oncology Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Frontier Science (Scotland) Ltd., Kincraig, UK. · Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Radiation Oncology Department, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, MD, USA. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Department of Oncology, Division of Cancer, Oslo University Hospital, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Medical Oncology Unit, Azienda Istituti Ospitalieri, Cremona, Italy. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Case Western Reserve University, Cleveland, OH, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 28376188
  • WELBIO and Institute of Interdisciplinary Research (IRIBHM), Campus Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium · ULB-Cancer Research Center (U-CRC) Université Libre de Bruxelles, Brussels, Belgium. · WELBIO and Institute of Interdisciplinary Research (IRIBHM), Campus Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Laboratoire de Biologie Moléculaire du Gène, Faculté des Sciences, Université libre de Bruxelles (ULB), Brussels, Belgium. · Center for Microscopy and Molecular Imaging, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Tumor Bank of the Jules Bordet Institute, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Biobank of the Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · ULB-Cancer Research Center (U-CRC) Université Libre de Bruxelles, Brussels, Belgium · Pubmed 28566333
  • Medical Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. · Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands; Department of Radiology, University Medical Centre Utrecht, Utrecht, The Netherlands. · Department of Surgery, Haaglanden Medical Centre, The Hague, The Netherlands. · Department of Statistics, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Department of Product Development and Support, Agendia, Amsterdam, The Netherlands. · Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland; Ludwig Center for Cancer Research, University of Lausanne, Epalinges, Switzerland; Department of Oncology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland. · Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Surgery, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Amsterdam, The Netherlands. Electronic address: · Pubmed 28477490
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Prometheus Laboratories, San Diego, California. · Foundation Medicine, Cambridge, Massachusetts. · Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, North Carolina. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Department of Gynecology, University of Ulm, Ulm, Germany. · Novartis Pharmaceuticals, Basel, Switzerland. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Pubmed 28381415
  • Breast Data Centre, Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Institute for Oncology and Radiology of Serbia, National Cancer Research Centre, Belgrade, Republic of Serbia. · Breast International Group, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Hospital Albert Einstein, São Paulo, Brazil. · Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Pubmed 28151718
2016
  • a Breast International Group (BIG) , Brussels , Belgium. · b European Organization for Research and Treatment of Cancer (EORTC) , Brussels , Belgium. · c Institut Jules Bordet, Université Libre de Bruxelles , Brussels , Belgium. · Pubmed 27741402
  • European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium. · Breast International Group (BIG), Brussels, Belgium. · University of Illinois and College of Medicine, Department of Molecular and Integrative Physiology, IL, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 27643748
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B 1000 Brussels, Belgium. Electronic address: · Pubmed 27430154
  • European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium. Electronic address: · European Centre for Disease Prevention and Control, Stockholm, Sweden. · European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium. · Breast Reconstruction Quality of Life Group, University of Bristol, Bristol, UK. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group, Brussels, Belgium. · Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Academic Medical Center, Amsterdam, Netherlands. · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Pubmed 27396647
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Department of Gynecology and Obstetrics, Ludwig-Maximilians-Universität, Munich, Germany. · Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Center of Experimental Medicine, Hamburg, Germany. · Circulating Biomarker Lab, SIRIC, Institut Curie, Paris, France. · Department of Medical Oncology, Institut Bergonié, Bordeaux, France. · Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna) and ACR-ITR VIEnna, Kaiser Franz Josef-Spital, Kundratstrasse 3, 1100 Vienna, Austria. · Medical and Scientific Affairs, F. Hoffmann-La Roche AG, Diagnostics Division, Basel, Switzerland. · European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium. · Breast International Group Headquarters, Brussels, Belgium. · Janssen Diagnostics LLC, NJ, USA. · Department of Gynecology and Obstetrics, Universitätsklinikum Ulm, Ulm, Germany. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Circulating Biomarker Lab, SIRIC, Institut Curie, Paris, France; Medical Oncology Department, Institut Curie, Université Paris Descartes, France. · Pubmed 27289552
  • Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group (BIG, aisbl), Brussels, Belgium. · Department of Medical Oncology, Hassan II University Hospital, Fez, Morocco. · Pubmed 26119941
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group (BIG aisbl), Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Medigene AG, Planegg, Germany. · Department of Biostatistics, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 27454930
  • Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Peninsula Oncology Centre, Melbourne, VIC, Australia. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · The Royal Marsden Hospital, London, UK. · Hospital Arnau de Vilanova, Lleida, Spain. · Sarah Cannon Research Institute, and Tennessee Oncology, Nashville, TN, USA. · Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic. · University of Alabama, Birmingham, AL, USA. · National University Hospital, Singapore. · Royal Melbourne Hospital, Parkville, VIC, Australia. · Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Herlev University Hospital, Copenhagen, Denmark. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Washington University School of Medicine, St Louis, MO, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Genentech, South San Francisco, CA, USA. · Barts Cancer Institute, Queen Mary University of London, London, UK. · Pubmed 27155741
  • EORTC-Headquarters, Medical Department, Brussels, Belgium. Electronic address: · Acıbadem Üniversitesi İç Hastalıkları/Tıbbi Onkoloji, Turkey. Electronic address: · EORTC-Headquarters, Statistical Department, Belgium. Electronic address: · Institute Bergonie, Bordeaux, France. Electronic address: · GZA Sint Augustinus, Antwerp, Belgium. Electronic address: · Ctr Becquerel-Rouen, France. Electronic address: · Radboudumc Nijmegen/Maastricht UMC+, Netherlands. Electronic address: · ZNA Middelheim, Belgium. Electronic address: · University Clinic Golnik, Slovenia. Electronic address: · Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. Electronic address: · NHS-Lothian, University of Edinburgh, Edinburgh, United Kingdom. Electronic address: · Pubmed 26724641
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast and Gynecological Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Avera Cancer Institute, Sioux Falls, South Dakota. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark11Department of Oncology, Odense University Hospital, Odense, Denmark12AgeCare, Odense University Hospital, Odense. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France14INSERM U1018, CESP, Université Paris-Sud, Villejuif France. · Pubmed 26633571
  • German Breast Group, Neu-Isenburg, Germany · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Surgery, Oncology and Gastroenterology, University of Padua, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · German Breast Group, Neu-Isenburg, Germany. · Frontier Science Scotland, Kincraig, UK. · Department of Medical Oncology, University of Verona, Verona, Italy. · Institute of Pathology, Charité Universitätsmedizin Berlin, and German Cancer Consortium (DKTK), Berlin. · Department of Obstetrics and Gynecology, University Hospital Kiel, Kiel, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussel, Belgium. · Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Obstetrics and Gynecology, Helios-Klinikum, Berlin-Buch, Germany. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 27177864
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
  • Unit of Biostatistics and Epidemiology, Gustave Roussy, Villejuif University Paris-Sud, University Paris-Saclay, UVSQ, CESP, INSERM, Villejuif Plateform Ligue nationale contre le cancer for meta-analyses in oncology, Gustave Roussy, Villejuif, France Institut Jules Bordet, Université Libre de Bruxelles, Brussels · Institut Jules Bordet, Université Libre de Bruxelles, Brussels Breast International Group (BIG), Brussels, Belgium. · Unit of Biostatistics and Epidemiology, Gustave Roussy, Villejuif. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany. · Department of Oncology, University of Edinburgh, Edinburgh, UK. · Rush University Medical Center, Chicago, USA. · Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Breast Unit, Royal Marsden Hospital, London, UK. · Scientific Direction, IRCCS National Cancer Research Centre "Giovanni Paolo II," Bari, Italy. · The Institute of Breast Oncology, Sheba Medical Center, Tel Hashomer, Israel. · Breast Cancer Diseases Unit and Department of Medical Oncology, Saint Louis Hospital, APHP, Paris, France. · German Breast Group, GBG ForschungsGmbH, Neu-Isenburg, Germany. · Department of Pathology, Centre Jean Perrin, EA 4233, University of Auvergne, Clermont-Ferrand, France. · Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles. · University of Miami School of Medicine, Comprehensive Cancer Research Group Inc, Columbia Cancer Research Network of Florida, Miami, USA. · IDDI, Louvain-la-Neuve, Hasselt University, Hasselt, Belgium. · Pubmed 26961151
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J. C. Heuson, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France. · Pubmed 26931736
  • Department of Medical Oncology, Institut Jules Bordet/Université libre de Bruxelles, 1 Rue Héger-Bordet, 1000 Bruxelles, Brussels, Belgium. · Department of Hematology and Oncology, Hôpital du Sacré-Cœur de Montréal/Université de Montréal, 5400 Boulevard Gouin, Montreal, Quebec H4J 1C5, Canada. · Pubmed 26787281
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue Yawkey, Boston, 1238, USA. · Department of Medical Oncology and Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK. · Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Royal Marsden Hospital, and Institute of Cancer Research, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Edinburgh Cancer Research Centre, Western general Hospital, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Department of Gynecology and Obstetrics and Multidisciplinary Breast Cancer Center, Helios Klinikum, Berlin-Buch, Germany. · Department of Gynecology and Obstetrics, Klinikum Off enbach, Off Enbach, Germany. · Department of Medical Oncology, The Andrew Love Cancer Centre, Deakin University, Geelong, Australia. · Department of Medical Oncology, San Raffaele Institute, Milan, Italy. · European Institute of Oncology, Milan, Italy. · Swiss Center for Breast Health, Sant'Anna Clinic, Lugano-Sorengo, Switzerland. · Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School, Boston, USA. · Pubmed 26708471
2015
  • Breast International Group (BIG, aisbl), Brussels, Belgium. · Breast European Adjuvant Studies Team (BrEAST), Brussels, Belgium. · Institut Jules Bordet, Université Libre des Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 26255196
  • Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Electronic address: · European Institute of Oncology, Division of Medical Oncology, Milan, Italy. · Department of Clinical Research, Institut Curie, Paris, France. · Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK, London Research Institute, London, UK. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breakthrough Breast Cancer Research Centre, Institute of Cancer Research and Kings College London School of Medicine, London, UK. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25840656
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 25712461
  • Department of Oncology, University Hospital Zurich, Zurich, Switzerland. Electronic address: · EORTC Headquarters, Brussels, Belgium. Electronic address: · Division of Medical Oncology, Second University of Naples, Naples, Italy. Electronic address: · KU Leuven - University of Leuven, Department of Oncology, Experimental Radiation Oncology, B-3000 Leuven, Belgium; University Hospitals Leuven, Department of Radiation Oncology, B-3000 Leuven, Belgium. Electronic address: · Medical University of Vienna, Vienna, Austria. Electronic address: · Institut de Cancérologie Gustave-Roussy, Villejuif, France; University Paris-Sud, Le Kremlin Bicêtre, Paris, France. Electronic address: · University of Dublin, Trinity College, Dublin, Ireland. Electronic address: · Université Paris Descartes, Paris, France. Electronic address: · Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. Electronic address: · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · VU Medical Center, Amsterdam, The Netherlands. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · University Hospitals Leuven and KU Leuven, Leuven, Belgium. Electronic address: · University Hospitals Leuven and KU Leuven, Leuven, Belgium. Electronic address: · Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: · Pubmed 25533737
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000 Brussels, Belgium. · Pubmed 25286972
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pathology Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital, Campus Mitte, German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland. · Pubmed 26358523
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · IRIBHM, Université Libre de Bruxelles (ULB), Route de Lennik, 808-1070 Brussels, Belgium. · Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK. · Department of Pathology, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Molecular Immunology Unit, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · Department of Medicine, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · Department of Genetics, Hôpital Erasme, Route de Lennik, 808-1070 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium; Department of Medicine, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. Electronic address: · IRIBHM, Université Libre de Bruxelles (ULB), Route de Lennik, 808-1070 Brussels, Belgium; WELBIO, Route de Lennik, 808-1070 Brussels, Belgium. Electronic address: · Pubmed 26440892
  • Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital Campus Mitte, and German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University, Hospital and Helsinki University, Helsinki, Finland. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Pathology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, University of Tampere and Tampere University Hospital, PO Box 607, FIN 33101, Tampere, Finland. · Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Pubmed 26234940
  • Department of Medical Oncology, National Institute of Oncology, Université Mohammed V de Rabat, Avenue Allal El Fassi, 10100, Rabat, Morocco. · Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000, Brussels, Belgium. · Department of Medical Oncology, National Institute of Oncology, Université Mohammed V de Rabat, Avenue Allal El Fassi, 10100, Rabat, Morocco. · Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000, Brussels, Belgium. · Pubmed 25971303
2014
  • BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25336696
  • 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Breast Cancer Translational Research Laboratory - J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory - J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. · Medical Oncology, Nepean Hospital, Penrith, NSW, Australia. · Breast International Group Executive Board. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium [3] Breast International Group Executive Board. · Pubmed 25225904
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. Electronic address: · Pubmed 25151406
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Department of Breast Medical Oncology, Multidisciplinary Breast Cancer Research Program, University of Texas MD Anderson Cancer Center, Houston, USA. · Institut de Cancérologie de l'Ouest, René Gauducheau, Centre de Recherche en Cancérologie, Nantes Saint Herblain, France. · Department of Medicine, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo. · Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. · Breast Cancer Centers, Memorial Cancer Institute, Hollywood. · Breast Oncology and Clinical Trials Education, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Oncologic Centre, AZ Nikolaas, Sint-Niklaas, Belgium. · Sarah Cannon Research Institute, Nashville, USA. · Centre des Maladies du Sein Deschênes-Fabia, CHU-Hôpital du Saint Sacrement, Québec, Canada. · Multidisciplinary Breast Centre and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Ironwood Cancer & Research Centers, Chandler. · Novartis Pharmaceuticals Corporation, East Hanover. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 25231953
  • Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France · European Organisation for Research and Treatment of Cancer (EORTC), Brussels. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France. · Centre George-François Leclerc, Dijon. · Ensemble Hospitalier de L'Institut Curie, Hopital René Huguenin, St-Cloud. · Centre Paul Strauss, Strasbourg. · Centre Val D'Aurelle-Paul Lamarque, Montpellier, France. · Medical University, Gdansk, Poland. · Centre Henri Becquerel, Rouen, France. · Geneva University Hospital, Geneva Swiss Group for Clinical Cancer Research (SAKK), Bern. · Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Institute of Oncology, Ljubljana University Clinic Golnik, Golnik, Slovenia. · Institut de Cancérologie de L'Ouest (ICO), Centre René Gauducheau, Nantes Centre Paul Papin, Angers. · Centre Alexis Vautrin, Nancy, France. · Department of Clinical Sciences, Lund University, Lund Skåne Department of Oncology, Skåne University Hospital, Lund. · Swedish Breast Cancer Group (SweBCG), Stockholm Department of Oncology, Karolinska Institutet, Radiumhemmet and Karolinska University Hospital, Stockholm, Sweden. · Cancer Services, Edinburgh University Anglo-Celtic Cooperative Oncology Group (ACCOG), Edinburgh, UK. · Pubmed 24618153
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. · Research Center of Epidemiology, Biostatistics and Clinical Research, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP598, Route de Lennik 808, 1070 Brussels, Belgium. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Department of Medical Oncology, Hirslanden Clinic Aarau, Schänisweg, 5001 Aarau, Switzerland. · Research Center of Social Approaches of Health, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP 596, Route de Lennik, 808, 1070 Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. Electronic address: · Pubmed 25446375
  • Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · OncoDNA, Gosselies, KU Leuven, Leuven. · Laboratory of Translational Genetics, KU Leuven, Leuven Vesalius Research Center, VIB, Leuven, Belgium. · Department of Biostatistic and Epidemiology, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Radiology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · Department of Pathology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels · Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels · Pubmed 25185240
2013
  • Author's Affiliation: Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24062313
2017
  • From the German Breast Group, Neu-Isenburg, Germany (G.M.); Frontier Science (Scotland), Kincraig, United Kingdom (M. Procter); the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), and Institut Jules Bordet, Université Libre de Bruxelles (M. Piccart) - all in Brussels; Roche Pharma (M.B., E.C., A.K.) and the Department of Cardiology, Cardio-Oncology, Bern University Hospital (T.S.) - both in Bern, Switzerland; the Department of Pathology, European Institute of Oncology, University of Milan, Milan (G.V.); the National Institute of Oncology, Budapest, Hungary (I.L.); Centre François Baclesse, Caen, France (C.L.); the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.A.Y.); Instituto Nacional de Câncer, Rio de Janeiro (J. Bines); Dana-Farber Cancer Institute, Harvard Medical School, Harvard T. H. Chan School of Public Health, and Frontier Science and Technology Research Foundation - all in Boston (R.D.G.); and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (J. Baselga). · Pubmed 28581356
2016
  • From Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal (F.C.); Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (L.J.V.); European Organization for Research and Treatment of Cancer Headquarters (J.B., L. Slaets, V.G., B.M., K.T.), Breast International Group Headquarters (T.G., C. Straehle), and Institut Jules Bordet, Université Libre de Bruxelles (C. Sotiriou, M.P.), Brussels, and Centre Hospitalier Universitaire Université Catholique de Louvain, Namur (P.V.) - both in Belgium; University of Milan and Istituto Europeo di Oncologia (G.V.) and Europa Donna-European Breast Cancer Coalition (S.K.), Milan, and Azienda Istituti Ospitalieri di Cremona, Cremona (R.P.) - both in Italy; Gustave Roussy, Villejuif (S.D., M.S.), Institut Curie Paris Sciences et Lettres, Université Paris Descartes, Sorbonne Paris Cité, Paris (J.-Y.P.). Institut Curie-Hôpital Rene Huguenin, Saint-Cloud (E.B.), and Centre Georges-Francois-Leclerc, Dijon (S.C.) - all in France; Swiss Institute of Bioinformatics and University of Lausanne, Lausanne, Switzerland (M.D.); Agendia (A.M.G., L. Stork) and the Netherlands Cancer Institute (R.B., E.R.), Amsterdam, Alrijne Ziekenhuis, Rijnland Leiderdorp (P.A.N.), Jeroen Bosch Hospital, 's-Hertogenbosch (T.J.S.), and Medisch Centrum Alkmaar, Alkmaar (J.M.H.) - all in the Netherlands; Institute of Oncology, Ljubljana, Slovenia (E.M.); Evangelisches Krankenhaus Bethesda, Duisburg, Germany (U.N.); University of Texas Health Sciences Center, San Antonio (P.R.); Hospital Universitario Vall d'Hebron, Barcelona (I.T.R.); Imperial College London, London (G.T.); and University of Texas M.D. Anderson Cancer Center, Houston (A.M.T.). · Pubmed 27557300
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
  • Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ; Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels; Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium; Hope S. Rugo, University of California, San Francisco; Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA; Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada; Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain; Thomas Bachelot, Centre Léon Bérard, Lyon, France; Shinzaburo Noguchi, Osaka University Medical School; Norikazu Masuda, Osaka National Hospital, Osaka, Japan; Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL; Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ; Shaker Dakhil, Cancer Center of Kansas, Wichita, KS; Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA; and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ; Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels; Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium; Hope S. Rugo, University of California, San Francisco; Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA; Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada; Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain; Thomas Bachelot, Centre Léon Bérard, Lyon, France; Shinzaburo Noguchi, Osaka University Medical School; Norikazu Masuda, Osaka National Hospital, Osaka, Japan; Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL; Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ; Shaker Dakhil, Cancer Center of Kansas, Wichita, KS; Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA; and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 26503204
2014
  • Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 25049332
  • Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium. · Pubmed 24667715
  • Department of Surgery and GROW School for Oncology and Developmental Biology (MM, MLS), Department of Surgery and Radiology (LMvR), Department of Medical Oncology, GROW School for Oncology and Developmental Biology (VCGTH), and Department of Epidemiology and GROW School for Oncology and Developmental Biology (ACV), Maastricht University Medical Center, Maastricht, the Netherlands; Department of Surgery, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands (LJAS); Division of Medical Oncology, Luzerner Kantonsspital, Lucerne, Switzerland (SA); Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian (DAC), Edinburgh Breast Unit (JMD), Western General Hospital, Edinburgh, UK; Cedars-Sinai Medical Center, Los Angeles, CA (AEG); Rutgers Cancer Institute of New Jersey, New Brunswick, NJ (BGH); Mater Centre Radiation Oncology Service, Princess Alexandra Hospital, Brisbane, Australia (BEH); Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center and Professor of Medicine, Weill Cornell Medical College, New York, NY (CAH); University of Arkansas for Medical Sciences, Winthrop P. Rockefeller Cancer Institute, Little Rock, AR (VSK); Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, Australia (BK); Interdisciplinary Breast Centre, Department of Gynaecology and Obstetrics, Klinikum Esslingen, Germany (TK); University of Miami Miller School of Medicine, Miami, FL (MEL); Radiation Oncology (BDS) and Department of Surgical Oncology, Division of Surgery (AL), University of Texas/MD Anderson Cancer Center, Houston, TX; Institut Jules Bordet, Université Libre de Bruxelles, Head of Medicine Department, Brussels, Belgium (MP); Surgery, University Medical Center, Leiden, the Netherlands (CJHvdV); Breast Service, Memorial Sloan-Kettering Cancer Center, Evelyn Lauder Breast Center, New York, NY(KJVZ); Antwerp University Hospital, Department of Medical Oncology, Edegem, Belgium (JBV); Department of Pathology, European Institute of · Pubmed 25381395
  • Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumDepartment of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxel · Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 24825746
2013
  • From the Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Edinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, United Kingdom; and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Pubmed 23714441
  • Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Pubmed 23459626
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23990869
  • Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY; James G. Greger Jr, GlaxoSmithKline, Collegeville, PA; Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles; Phuong Dinh, Breast International Group, Brussels; Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium; Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland; Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research, London, United Kingdom; Serena Di Cosimo, IRCCS Fondazione Instituto Nazionale dei Tumori, Milan, Italy; Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain; Christian Jackisch, Kilinikum Offenbach, Offenbach; Bahriye Aktas, Kliniken Essen-Mitte, Evang, Essen; Holger Eidtmann, University Hospital Kiel, Kiel, Germany; Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; Chiun-Sheng Huang, National Taiwan University Hospital; Ruey Kuen Hsieh, Mackey Memorial Hospital, Taipei, Taiwan; and Lydia Dreosti, University of Pretoria, Pretoria, South Africa. · Pubmed 24248687
  • Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24092940
  • Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23778140
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23739063
  • Breast Cancer Translational Research Laboratory, JC Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23638089
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23169515
  • Breast Cancer Translation Research Laboratory J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23028037
2012
  • Breast Cancer Translational Research Laboratory, Faculty of Medicine, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Pubmed 22652232
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22508827
  • Breast Cancer Translational Research Laboratory (BCTL) J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22261811
2011
  • Breast Cancer Translational Research Laboratory, Faculty of Medicine, Université Libre de Bruxelles, Institut Jules Bordet, Bruxelles 1000, Belgium. · Pubmed 22043058
  • Laboratory of Cancer Epigenetics, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 21910250
  • Translational Research Unit, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 21738599
  • Department of Medical Oncology, Institut Jules Bordet, Universite Libre de Bruxelles, 1000 Brussels, Belgium. · Pubmed 21354372
2009
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 19289395
Miscellaneous institutions in Brussels
2016
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group (BIG aisbl), Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Medigene AG, Planegg, Germany. · Department of Biostatistics, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 27454930
2011
66 Other Locations Show
Yearly article counts 1102115222411145200
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.